JP5774986B2 - Vesicle composition and cosmetics containing the same - Google Patents
Vesicle composition and cosmetics containing the same Download PDFInfo
- Publication number
- JP5774986B2 JP5774986B2 JP2011518603A JP2011518603A JP5774986B2 JP 5774986 B2 JP5774986 B2 JP 5774986B2 JP 2011518603 A JP2011518603 A JP 2011518603A JP 2011518603 A JP2011518603 A JP 2011518603A JP 5774986 B2 JP5774986 B2 JP 5774986B2
- Authority
- JP
- Japan
- Prior art keywords
- hair
- component
- vesicle
- vesicle composition
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 103
- 239000002537 cosmetic Substances 0.000 title claims description 66
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 235000012000 cholesterol Nutrition 0.000 claims description 20
- 239000003093 cationic surfactant Substances 0.000 claims description 16
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 claims description 15
- WQMJXFAFCDSZKC-UHFFFAOYSA-M bis(2-hexadecanoyloxyethyl)-(2-hydroxyethyl)-methylazanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCC(=O)OCC[N+](C)(CCO)CCOC(=O)CCCCCCCCCCCCCCC WQMJXFAFCDSZKC-UHFFFAOYSA-M 0.000 claims description 3
- 229940090933 dipalmitoylethyl hydroxyethylmonium methosulfate Drugs 0.000 claims description 3
- -1 cholesterol Chemical class 0.000 description 61
- 235000014113 dietary fatty acids Nutrition 0.000 description 36
- 239000000194 fatty acid Substances 0.000 description 36
- 229930195729 fatty acid Natural products 0.000 description 36
- 239000000843 powder Substances 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 23
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 20
- 230000035515 penetration Effects 0.000 description 20
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- 239000002245 particle Substances 0.000 description 18
- 229930182558 Sterol Natural products 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 17
- 150000004665 fatty acids Chemical class 0.000 description 17
- 150000003432 sterols Chemical class 0.000 description 17
- 235000003702 sterols Nutrition 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 16
- 238000002156 mixing Methods 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 13
- 239000003676 hair preparation Substances 0.000 description 12
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 11
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 11
- 230000003696 hair cross section Effects 0.000 description 11
- 239000008213 purified water Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000004166 Lanolin Substances 0.000 description 9
- 125000005210 alkyl ammonium group Chemical group 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 235000019388 lanolin Nutrition 0.000 description 9
- 229940039717 lanolin Drugs 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 230000002123 temporal effect Effects 0.000 description 9
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 6
- 230000000149 penetrating effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 244000027321 Lychnis chalcedonica Species 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- ZFGOPJASRDDARH-UHFFFAOYSA-N 3-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C(C2)C1(C)CCC2OC1CC2=CCC3C4CCC(C(C)CCCC(C)C)C4(C)CCC3C2(C)CC1 ZFGOPJASRDDARH-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical group 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 231100000640 hair analysis Toxicity 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 239000010466 nut oil Substances 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 2
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 2
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 239000003012 bilayer membrane Substances 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 230000003699 hair surface Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- YYVJAABUJYRQJO-UHFFFAOYSA-N isomyristic acid Chemical compound CC(C)CCCCCCCCCCC(O)=O YYVJAABUJYRQJO-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 239000010667 rosehip oil Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 125000002328 sterol group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940041603 vitamin k 3 Drugs 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- HZVFRKSYUGFFEJ-YVECIDJPSA-N (2r,3r,4s,5r)-7-phenylhept-6-ene-1,2,3,4,5,6-hexol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=CC1=CC=CC=C1 HZVFRKSYUGFFEJ-YVECIDJPSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- WPIOBXGJZUSKGK-UHFFFAOYSA-N 16-methylheptadecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C WPIOBXGJZUSKGK-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- XFBOJHLYDJZYSP-UHFFFAOYSA-N 2,8-dioxoadenine Chemical compound N1C(=O)N=C2NC(=O)NC2=C1N XFBOJHLYDJZYSP-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- NBAGECZCEDXIKB-UHFFFAOYSA-N 2-ethylhexanoic acid;hexadecanoic acid Chemical compound CCCCC(CC)C(O)=O.CCCCCCCCCCCCCCCC(O)=O NBAGECZCEDXIKB-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- KIZQNNOULOCVDM-UHFFFAOYSA-M 2-hydroxyethyl(trimethyl)azanium;hydroxide Chemical compound [OH-].C[N+](C)(C)CCO KIZQNNOULOCVDM-UHFFFAOYSA-M 0.000 description 1
- FPKBRMRMNGYJLA-UHFFFAOYSA-M 2-hydroxyethyl-methyl-bis(2-octadecanoyloxyethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC FPKBRMRMNGYJLA-UHFFFAOYSA-M 0.000 description 1
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- DSVUBXQDJGJGIC-UHFFFAOYSA-N 3',6'-dihydroxy-4',5'-diiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(I)=C1OC1=C(I)C(O)=CC=C21 DSVUBXQDJGJGIC-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ANRUJJLGVODXIK-UHFFFAOYSA-N 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide Chemical compound NCCC(=O)NCCC1=CN=CN1 ANRUJJLGVODXIK-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- RHAXKFFKGZJUOE-UHFFFAOYSA-N 7-acetyl-6-ethyl-3,5,8-trihydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid Chemical compound O=C1C2=CC(O)=C(C(O)=O)C(C(O)=O)=C2C(=O)C2=C1C(O)=C(CC)C(C(C)=O)=C2O RHAXKFFKGZJUOE-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000237519 Bivalvia Species 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- PZMJFZVXEOVHBC-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO Chemical compound C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO.C(CCCCCCCCCCCCCCC(C)C)(=O)OCO PZMJFZVXEOVHBC-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229930192967 Laccaic acid Natural products 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- DGOBMKYRQHEFGQ-UHFFFAOYSA-L acid green 5 Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 DGOBMKYRQHEFGQ-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- DHJGVCITGOCTCA-UHFFFAOYSA-L calcium;hexadecyl phosphate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCOP([O-])([O-])=O DHJGVCITGOCTCA-UHFFFAOYSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 108700021352 carcinine Proteins 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- HBHZKFOUIUMKHV-UHFFFAOYSA-N chembl1982121 Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HBHZKFOUIUMKHV-UHFFFAOYSA-N 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 229940030620 distearoylethyl hydroxyethylmonium methosulfate Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- WYVGZXIHGGQSQN-UHFFFAOYSA-N hexadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(O)=O WYVGZXIHGGQSQN-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- QICHMCRJUKQZRE-UHFFFAOYSA-N hexadecyl decanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCC QICHMCRJUKQZRE-UHFFFAOYSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052809 inorganic oxide Inorganic materials 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940100434 menadiol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229940079938 nitrocellulose Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- BPHQIXJDBIHMLT-UHFFFAOYSA-N perfluorodecane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F BPHQIXJDBIHMLT-UHFFFAOYSA-N 0.000 description 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- CBXWGGFGZDVPNV-UHFFFAOYSA-N so4-so4 Chemical compound OS(O)(=O)=O.OS(O)(=O)=O CBXWGGFGZDVPNV-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- VVNRQZDDMYBBJY-UHFFFAOYSA-M sodium 1-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalen-2-olate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C21 VVNRQZDDMYBBJY-UHFFFAOYSA-M 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- NOJQBSUJVLPAQO-UHFFFAOYSA-L sodium;zinc;hexadecyl phosphate Chemical compound [Na+].[Zn+2].CCCCCCCCCCCCCCCCOP([O-])([O-])=O NOJQBSUJVLPAQO-UHFFFAOYSA-L 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- QIWDGSYHBCMXSI-UHFFFAOYSA-J tetrasodium;(2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].C1=CC=CC2=C(OP([O-])([O-])=O)C(C)=CC(OP([O-])([O-])=O)=C21 QIWDGSYHBCMXSI-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 229940057977 zinc stearate Drugs 0.000 description 1
- 229940118257 zinc undecylenate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
- KUPGJMJHAFGISS-UHFFFAOYSA-L zinc;hexadecyl phosphate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCOP([O-])([O-])=O KUPGJMJHAFGISS-UHFFFAOYSA-L 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
本発明は、特定のカチオン性界面活性剤とステロール類と水を構成要素とする経時安定性に優れるベシクル組成物及びそれを配合した化粧料に関するものであり、特には、該組成物を配合した毛髪用化粧料であって、毛髪に適用した場合、毛髪に素早くなじみ、毛髪内部への浸透性に優れ、しっとり感の付与に優れる毛髪用化粧料に関するものである。 The present invention relates to a vesicle composition having a specific cationic surfactant, sterols, and water as constituents and excellent in stability over time, and a cosmetic containing the composition, and in particular, the composition. The present invention relates to a hair cosmetic composition that, when applied to hair, quickly adjusts to the hair, has excellent penetration into the hair, and provides a moist feeling.
従来より、コレステロールやフィトステロールなどのステロール類は、毛髪に有効な成分として、毛髪用化粧料への配合検討がなされている。特にコレステロールは毛髪の水分保持機能に関わる成分として元々毛髪内に存在しているが、その含有量は10才前後を境に減少すると言われており(非特許文献1参照)、パサつきのないしっとりとした美しい髪を保つための重要な成分の一つである。
しかし、コレステロールなどのステロール誘導体は、一般に、水にも油にも溶解しにくい難溶性の物質としても知られており(特許文献1参照)、特に、水を媒体とするローション系の製剤に安定に配合することは非常に困難である。そのため、これらの難溶性のステロール誘導体を水性媒体の化粧料に安定に配合する技術の研究が種々行われている。
例えば、4級アルキルアンモニウム塩型カチオン性界面活性剤と、両親媒性物質、ステロール誘導体、水を特定の配合比率において混合することにより、水相が内包されたラメラ液晶の2分子膜小胞体、すなわちベシクルが形成されることが知られている(特許文献2参照)。
また、別の検討として、4級アルキルアンモニウム塩型カチオン性界面活性剤と、ステロール誘導体、セラミドに、カチオン性高分子(特許文献3参照)やシリコーンを(特許文献4参照)配合することにより、ベシクルが形成されることも知られている。
更に、上記特許文献2〜4とは異なるカチオン性界面活性剤として、疎水基内にエステル構造を有するジココイルエチルヒドロキシエチルモニウムメトサルフェートを用いて、コレステロールなどのステロール類を配合した例もある(特許文献5参照)。Conventionally, sterols such as cholesterol and phytosterol have been studied for incorporation into hair cosmetics as effective components for hair. In particular, cholesterol is originally present in hair as a component related to the moisture retention function of hair, but its content is said to decrease around the age of 10 (see Non-Patent Document 1), and it is moist and dry. It is one of the important ingredients for keeping beautiful hair.
However, sterol derivatives such as cholesterol are generally known as poorly soluble substances that are hardly soluble in water and oil (see Patent Document 1), and are particularly stable in lotion-based preparations using water as a medium. It is very difficult to blend in. For this reason, various studies have been conducted on techniques for stably blending these poorly soluble sterol derivatives into cosmetics in aqueous media.
For example, by mixing a quaternary alkyl ammonium salt type cationic surfactant with an amphiphile, a sterol derivative, and water at a specific blending ratio, a bilayer membrane vesicle of lamellar liquid crystal containing an aqueous phase, That is, it is known that vesicles are formed (see Patent Document 2).
As another study, by adding a cationic polymer (see Patent Document 3) and silicone (see Patent Document 4) to a quaternary alkyl ammonium salt type cationic surfactant, a sterol derivative, and a ceramide, It is also known that vesicles are formed.
Furthermore, there is an example in which sterols such as cholesterol are blended using dicocoylethylhydroxyethylmonium methosulfate having an ester structure in a hydrophobic group as a cationic surfactant different from those in Patent Documents 2 to 4 above ( (See Patent Document 5).
しかしながら、特許文献2〜4の技術は、いずれも4級アルキルアンモニウム塩型カチオン性界面活性剤を用いたものであり、4級アルキルアンモニウム塩型カチオン性界面活性剤を用いたのでは、ステロール類のベシクル化が十分に行なわれない場合や、経時でベシクルが壊れ析出し結晶化して沈殿するなど安定性が十分でない場合があった。更にこのようなベシクルを毛髪用化粧料に配合し毛髪に適用しても、毛髪になじみ、毛髪内部に浸透していく感じ;浸透感が得られにくく、しっとり感も得がたいという問題があった。 However, all of the techniques of Patent Documents 2 to 4 use a quaternary alkyl ammonium salt type cationic surfactant, and if a quaternary alkyl ammonium salt type cationic surfactant is used, sterols In some cases, vesicles were not sufficiently formed, or the vesicles were broken and precipitated over time, and crystallized and precipitated. Furthermore, even when such vesicles are blended into hair cosmetics and applied to hair, there is a problem that it feels familiar with the hair and penetrates into the hair; it is difficult to obtain a sense of penetration and it is difficult to obtain a moist feeling.
また、特許文献5によれば、コレステロール等の難溶性成分は、ベシクル中に安定配合できない場合があり、そのため経時でコレステロール等が析出してしまい、毛髪に有効な効果をもたらし難いという問題があった。 Further, according to Patent Document 5, a poorly soluble component such as cholesterol may not be stably blended in a vesicle, so that cholesterol and the like are precipitated over time, and it is difficult to bring about an effective effect on hair. It was.
従って、本発明は毛髪に有効な成分であるコレステロール等のステロール類を水系媒体に安定に配合でき、且つ経時安定性に優れるベシクル組成物及びそれを配合した化粧料を提供することを課題とする。特には、該組成物を配合した毛髪用化粧料であって、毛髪に適用した場合には、毛髪に素早くなじみ、毛髪内部への浸透性に優れ、しっとり感を付与する効果に優れた毛髪用化粧料を提供することを課題とする。 Accordingly, an object of the present invention is to provide a vesicle composition that can stably blend sterols such as cholesterol, which is an effective ingredient for hair, into an aqueous medium, and that is excellent in stability over time, and a cosmetic comprising the same. . In particular, it is a cosmetic for hair formulated with the composition, and when applied to hair, it is adapted to hair quickly, has excellent penetration into hair, and has a moisturizing effect. It is an object to provide cosmetics.
本発明者は、上記課題を解決するために鋭意研究を重ねた結果、特定の化学構造を有するカチオン性界面活性剤とステロール類、水を組み合わせることで、経時安定性に優れるベシクル組成物が得られ、該組成物を水系の化粧料に安定的に配合できること、更に、毛髪用化粧料に配合し、毛髪に適用した場合、化粧料が毛髪表面にいつまでも留まることなく素早くなじみ、毛髪内部への浸透性に優れ、有効成分が浸透していく感じを実感でき、しっとり感の付与効果に優れる毛髪用化粧料が得られることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above problems, the present inventors have obtained a vesicle composition having excellent temporal stability by combining a cationic surfactant having a specific chemical structure, sterols, and water. The composition can be stably blended in water-based cosmetics, and when blended in hair cosmetics and applied to hair, the cosmetics quickly adapt to the hair surface without staying on the hair surface. It has been found that a cosmetic for hair that is excellent in penetrability, can feel the permeation of active ingredients, and has a moist feeling imparting effect, and has completed the present invention.
すなわち、本発明は、次の成分(A)〜(C)、
(A) 下記の一般式(1)
(B) ステロール類
(C) 水
を含有することを特徴とするベシクル組成物を提供するものである。That is, the present invention includes the following components (A) to (C),
(A) The following general formula (1)
また、本発明は、成分(A)と成分(B)のモル比(A)/(B)が、100/1〜1/4の範囲内にあることを特徴とするベシクル組成物を提供するものである。 Moreover, this invention provides the vesicle composition characterized by the molar ratio (A) / (B) of a component (A) and a component (B) being in the range of 100/1-1/4. Is.
また、本発明は、成分(B)がコレステロール及び/又はフィトステロールであることを特徴とするベシクル組成物を提供するものである。 The present invention also provides a vesicle composition wherein component (B) is cholesterol and / or phytosterol.
また、本発明は、該ベシクル組成物を配合することを特徴とする化粧料を提供するものである。本発明の化粧料の好ましい態様は、毛髪用化粧料である。 Moreover, this invention provides the cosmetics characterized by mix | blending this vesicle composition. A preferred embodiment of the cosmetic of the present invention is a hair cosmetic.
また、本発明は、該ベシクル組成物、若しくは該化粧料に、更に成分(D)として、一価の低級アルコールを配合することを特徴とするものである。 In addition, the present invention is characterized in that a monovalent lower alcohol is further added as a component (D) to the vesicle composition or the cosmetic.
本発明のベシクル組成物は、経時安定性に優れるものであり、また化粧料に安定的に配合することができる。特に該組成物を配合した毛髪用化粧料は、毛髪に適用した場合には、毛髪へ素早くなじみ、毛髪内部への浸透性に優れ、浸透していく感じを実感でき、しっとり感の付与効果に優れている。 The vesicle composition of the present invention has excellent temporal stability and can be stably blended into cosmetics. In particular, hair cosmetics formulated with the composition, when applied to the hair, quickly adjust to the hair, have excellent penetration into the hair, can feel the penetration, and provide a moist feeling. Are better.
本発明について詳細に説明する。
本発明は、所定の成分(A)〜(C)を含有するベシクル組成物に関する。
なお、本明細書において「ベシクル組成物」とは、水中で球状の閉鎖小胞体を意味し、偏光顕微鏡観察でマルテローゼクロス像が観察されるものであり、また別の観察方法としては、透過型電子顕微鏡観察で多重層構造のマルチラメラベシクルが観察されるものをいう。The present invention will be described in detail.
The present invention relates to a vesicle composition containing predetermined components (A) to (C).
In the present specification, the “vesicle composition” means a closed spherical endoplasmic reticulum in water, in which a Martellose cross image is observed with a polarizing microscope, and another observation method is transmission. This means that multilamellar vesicles having a multi-layer structure are observed with a scanning electron microscope.
本発明に用いられる成分(A)のカチオン性界面活性剤は、下記の一般式(1)
本発明においては、成分(A)を用いることで、経時安定性に優れ、ベシクル構造における二分子膜の変形性を評価する微視的な膜流動性(以下、「ベシクル膜の変形性」と略す)にも優れたベシクル組成物を調製することができるので、成分(A)により形成されるベシクル中に後述する成分(B)を内包させると、成分(B)等の毛髪有効成分が経時で析出することなどがなく、使用時まで安定に保持できる。そして、毛髪に塗布した際には、毛髪内部まで効率的に浸透し、成分(B)等の毛髪有効成分を安定的に毛髪内部へ送達させ、しっとり感を付与する効果の高いものが得られる。
成分(A)の具体例としては、ジココイルエチルヒドロキシエチルモニウムメトサルフェート、ジステアロイルエチルヒドロキシエチルモニウムメトサルフェート、ジパルミトイルエチルヒドロキシエチルモニウムメトサルフェート等が挙げられ、これらを1種、又は2種以上組み合わせて使用でき、DEHYQUART L80、DEHYQUART F75、DEHYQUART AU56/G、DEHYQUART C4046(いずれもコグニス社製)などの市販品も使用可能である。このうち、特にジココイルエチルヒドロキシエチルモニウムメトサルフェートが、得られるベシクル組成物の経時安定性や、そのベシクル組成物を配合した毛髪用化粧料を毛髪に塗布した際の浸透性(浸透感)の点から好ましい。The component (A) cationic surfactant used in the present invention has the following general formula (1):
In the present invention, by using the component (A), microscopic membrane fluidity (hereinafter referred to as “deformability of the vesicle membrane”) is excellent in stability over time and evaluates the deformability of the bilayer membrane in the vesicle structure. A vesicle composition that is also excellent in abbreviations), and when the component (B) described later is encapsulated in the vesicle formed by the component (A), the active hair component such as the component (B) It can be kept stable until use. And when applied to the hair, it efficiently penetrates into the hair, and the active ingredients such as the component (B) are stably delivered into the hair, thereby giving a moist feeling. .
Specific examples of component (A) include dicocoylethylhydroxyethylmonium methosulfate, distearoylethylhydroxyethylmonium methosulfate, dipalmitoylethylhydroxyethylmonium methosulfate, and the like. Commercially available products such as DEHYQUAT L80, DEHYQUAT F75, DEHYQUAT AU56 / G, DEHYQUART C4046 (all manufactured by Cognis) can also be used. Of these, especially dicocoylethylhydroxyethylmonium methosulphate has the stability over time of the resulting vesicle composition and the permeability (penetration feeling) when a cosmetic for hair containing the vesicle composition is applied to the hair. It is preferable from the point.
本発明の成分(A)のベシクル組成物中の配合量は、特に限定されないが、0.001〜10質量%(以下、単に「%」と略す)が好ましく、0.01〜5%がより好ましい。
配合量がこの範囲であれば、経時安定性やベシクル膜の変形性に優れたベシクル組成物が得られるため、これを化粧料に配合した場合には、使用するまでは非常に安定で、例えば、毛髪に塗布した際には、成分(B)等の毛髪有効成分が毛髪内部まで効率的に浸透し、しっとり感に優れたものが得られる。The blending amount of the component (A) of the present invention in the vesicle composition is not particularly limited, but is preferably 0.001 to 10% by mass (hereinafter simply referred to as “%”), more preferably 0.01 to 5%. preferable.
If the blending amount is within this range, a vesicle composition excellent in stability over time and deformability of the vesicle film can be obtained.When blended in cosmetics, it is very stable until use, for example, When applied to the hair, an active hair component such as component (B) penetrates efficiently into the hair, and a moist feeling is obtained.
本発明に用いられる成分(B)のステロール類は、ベシクルの形成、安定化に寄与するとともに、得られたベシクル組成物を、毛髪用化粧料に配合した際の毛髪へのしっとり感の付与に寄与するものとして配合される。 The sterols of component (B) used in the present invention contribute to the formation and stabilization of vesicles, and also to impart a moist feeling to hair when the obtained vesicle composition is blended in hair cosmetics. Formulated as a contributor.
例えば、従来汎用されているカチオン界面活性剤として、エステル基を含まない長鎖アルキル基を有する、ジステアリルジメチルアンモニウムクロライド(ライオン・アクゾ社製)を含むベシクル系に、ステロール類を添加すると、ベシクル系が凝集等をおこす場合がある。しかしながらエステル基を含む長鎖アルキル鎖を含む上記所定の式(1)で表されるカチオン界面活性剤を含むベシクル系に、ステロール類を添加すると、予期せぬことに、ベシクル系を顕著に安定化することが、本発明者によって見出された。 For example, when a sterol is added to a vesicle system containing distearyldimethylammonium chloride (manufactured by Lion Akzo) having a long-chain alkyl group that does not contain an ester group as a conventionally used cationic surfactant, The system may cause aggregation. However, when sterols are added to a vesicle system containing a cationic surfactant represented by the above formula (1) containing a long alkyl chain containing an ester group, unexpectedly, the vesicle system is remarkably stabilized. Has been found by the present inventors.
成分(B)のステロール類は、ステロール骨格を持つ物質あるいはその誘導体であればいずれでもよく、例えば、コレステロール、フィトステロール(β−シトステロール、カンペステロール、スティグマステロール、ブラシカステロール等)、ラノステロール、ポリオキシエチレンコレステリルエーテル、マカデミアンナッツ油脂肪酸コレステリル、マカデミアンナッツ油脂肪酸フィトステリル、ヤシ油脂肪酸コレステリル、オレイン酸フィトステリル、N−ラウロイル−L−グルタミン酸ジ(コレステリル・ベヘニル・オクチルドデシル)、N−ラウロイル−L−グルタミン酸ジ(オクチルドデシル・フィトステリル・ベヘニル)、N−ラウロイル−L−グルタミン酸ジ(フィトステリル・オクチルドデシル)、オレイン酸フィトステリル等が挙げられ、これらの1種又は2種以上を用いることができるが、中でも、下記一般式(2)に示すステロール骨格を有し、及びRが脂肪族基(例えば、直鎖状もしくは分岐鎖状のアルキル基、及び直鎖状もしくは分岐鎖状のアルケニル基)であるステロール類が好ましく、特に、コレステロール、フィトステロールが好ましい。 The component (B) sterols may be any substance having a sterol skeleton or a derivative thereof. For example, cholesterol, phytosterol (β-sitosterol, campesterol, stigmasterol, brassicasterol, etc.), lanosterol, polyoxyethylene Cholesteryl ether, macadamian nut oil fatty acid cholesteryl, macadamian nut oil fatty acid phytosteryl, palm oil fatty acid cholesteryl, phytosteryl oleate, N-lauroyl-L-glutamate di (cholesteryl behenyl octyldodecyl), N-lauroyl-L-glutamic acid Di (octyldodecyl phytosteryl behenyl), N-lauroyl-L-glutamate di (phytosteryl octyldodecyl), phytosteryl oleate 1 or 2 or more of these can be used, and among them, it has a sterol skeleton represented by the following general formula (2), and R is an aliphatic group (for example, linear or branched) Sterols which are a chain alkyl group and a linear or branched alkenyl group) are preferable, and cholesterol and phytosterol are particularly preferable.
市販品としては、ニッスイマリンコレステロール(日本水産社製)、マリンコレステロール(共和テクノス社製)、フィトステロール(エーザイ・フードケミカル社製)、ライスステロール(築野ライスファインケミカルズ社製)、EMALEX CS−10(日本エマルジョン社製)、エルデュウ PS−203、エルデュウ PS−304、エルデュウ PS−306(以上、味の素社製)等が使用可能である。 Commercially available products include Nissui Marine Cholesterol (manufactured by Nippon Suisan), Marine Cholesterol (manufactured by Kyowa Technos), Phytosterol (manufactured by Eisai Food Chemical), Rice Sterol (manufactured by Tsukino Rice Fine Chemicals), EMALEX CS-10 ( Nippon Emulsion Co., Ltd.), El Dew PS-203, El Deu PS-304, El Deu PS-306 (above, manufactured by Ajinomoto Co., Inc.) and the like can be used.
本発明の成分(B)の配合量は、特に限定されないが、ベシクル組成物中0.001〜5%が好ましく、0.01〜3%がより好ましい。この範囲で用いれば、ベシクル組成物が良好に形成され、経時安定性に優れ、成分(B)が有効に毛髪内部に浸透するため、十分なしっとり感を感じることができる。 Although the compounding quantity of the component (B) of this invention is not specifically limited, 0.001 to 5% is preferable in a vesicle composition, and 0.01 to 3% is more preferable. When used in this range, the vesicle composition is well formed, has excellent stability over time, and the component (B) effectively penetrates into the hair, so that a sufficiently moist feeling can be felt.
また、本発明の成分(A)と成分(B)の配合比は、成分(B)に対する成分(A)のモル比(A)/(B)が、100/1〜1/4が好ましく、9/1〜3/7の範囲内にあることがより好ましい。(A)/(B)のモル比が、この範囲であれば、微視的な膜流動性(ベシクル膜の変形性)に優れ、経時安定性に優れたベシクル組成物となり、毛髪に対して有効な成分(B)を効率的に毛髪内部に浸透させることができ、成分(B)の効果をよりよく発揮できる。 Moreover, as for the compounding ratio of the component (A) and the component (B) of the present invention, the molar ratio (A) / (B) of the component (A) to the component (B) is preferably 100/1 to 1/4, More preferably, it is in the range of 9/1 to 3/7. When the molar ratio of (A) / (B) is within this range, the vesicle composition is excellent in microscopic membrane fluidity (deformability of vesicle membrane) and excellent in aging stability, The effective component (B) can efficiently penetrate into the hair, and the effect of the component (B) can be exhibited better.
本発明に用いられる成分(C)の水は、ベシクルの分散媒体として用いられるものであり、ベシクル組成物及びそれを配合する化粧料の媒体として必須の成分である。その配合量は、他の成分、すなわち、成分(A)、(B)、或いは成分(A)、(B)及び後述する成分(D)や任意に配合する成分の量により適宜決められるが、概ね5〜99%、より好ましくは20〜90%、そしてさらに好ましくは60〜90%の範囲で用いることができる。 The component (C) water used in the present invention is used as a dispersion medium for vesicles, and is an essential component as a medium for vesicle compositions and cosmetics containing them. The blending amount is appropriately determined depending on the amount of other components, that is, the components (A) and (B), or the components (A) and (B), the component (D) described later, and components to be blended arbitrarily. Generally, it can be used in the range of 5 to 99%, more preferably 20 to 90%, and still more preferably 60 to 90%.
本発明のベシクル組成物には、上記成分(A)〜(C)の他に、成分(B)の結晶析出に対する経時安定性をより向上させる目的で、25℃において液状である高級脂肪酸を配合することができる。25℃において液状の高級脂肪酸であればいずれを用いてもよく、例えば、イソミリスチン酸、イソパルミチン酸、イソステアリン酸等の飽和分岐脂肪酸や、オレイン酸、リノール酸等の不飽和脂肪酸等が挙げられる。また不飽和脂肪酸を含む植物油としては、アボカド油、アルモンド油、精製ホホバ油、グレープシード油、ゴマ油、小麦胚芽油、コメヌカ油、大豆油、トウモロコシ胚芽油、ナタネ油、マカデミアナッツ油、メドウホーム油、ピーナッツ油、ローズヒップ油等を用いてもよい。25℃における液状の高級脂肪酸の含有量としては、成分(B)に対して質量比で0.5〜1.5倍量が好ましいものとして挙げられる。 In addition to the above components (A) to (C), the vesicle composition of the present invention contains a higher fatty acid that is liquid at 25 ° C. for the purpose of further improving the temporal stability of the component (B) against crystal precipitation. can do. Any higher fatty acid that is liquid at 25 ° C. may be used, and examples thereof include saturated branched fatty acids such as isomyristic acid, isopalmitic acid and isostearic acid, and unsaturated fatty acids such as oleic acid and linoleic acid. . Vegetable oils containing unsaturated fatty acids include avocado oil, almond oil, refined jojoba oil, grape seed oil, sesame oil, wheat germ oil, rice bran oil, soybean oil, corn germ oil, rapeseed oil, macadamia nut oil, meadow home oil, Peanut oil, rosehip oil, or the like may be used. As content of the liquid higher fatty acid in 25 degreeC, 0.5-1.5 times amount is mentioned by a mass ratio with respect to a component (B) as a preferable thing.
本発明のベシクル組成物の製造方法としては、特に限定されないが、例えば、100℃以上に加温した成分(A)、(B)を、90℃以上に加温した成分(C)に分散させ、その後攪拌を続けながら徐々に室温まで冷却させることにより得られる。また、使用感や毛髪への更なる効果等を期待して後述するような任意に配合可能な成分をベシクル調製時に、適宜その性質等に応じて加えても良い。
得られたベシクル組成物の平均粒子径は、概ね100nm〜10μmであるが、好ましくは後述するエクストルーダー等の機器を用いて平均粒子径を50〜500nmとすることにより、経時でもベシクルが崩壊することがなく、平均粒子径の変化(増大)も少ない安定性に優れたものが得られる。The method for producing the vesicle composition of the present invention is not particularly limited. For example, components (A) and (B) heated to 100 ° C. or higher are dispersed in component (C) heated to 90 ° C. or higher. Then, it is obtained by gradually cooling to room temperature while continuing stirring. Moreover, you may add the component which can be mix | blended arbitrarily as mentioned later in anticipation of the usability, the further effect on hair, etc. according to the property etc. suitably at the time of vesicle preparation.
The average particle size of the obtained vesicle composition is about 100 nm to 10 μm. Preferably, the average particle size is set to 50 to 500 nm using an apparatus such as an extruder, which will be described later, so that the vesicle disintegrates even with time. In other words, a product excellent in stability with little change (increase) in the average particle size can be obtained.
上記方法等によって調製される本発明のベシクル組成物は、これを毛髪用化粧料等の種々の化粧料に配合することができる。特に、本発明のベシクル組成物が配合された毛髪用化粧料は、有効成分の毛髪内部への浸透性に優れるので好ましい。 The vesicle composition of the present invention prepared by the above method can be blended in various cosmetics such as hair cosmetics. In particular, a hair cosmetic blended with the vesicle composition of the present invention is preferable because it has excellent penetrability of the active ingredient into the hair.
本発明は、本発明のベシクル組成物を配合した化粧料にも関する。本発明のベシクル組成物を配合した化粧料には、成分(D)として、低級一価アルコールを配合することができる。
成分(D)の低級一価アルコールは、一般に毛髪用化粧料において、塗布時の乾きの速さや清涼感を奏する上で重要な成分とされており、毛髪へのなじみの良さに寄与するが、ベシクル組成物配合系においては、低級一価アルコールを配合することは経時安定性の確保を困難にするものとして知られている。
しかしながら、本発明においては、上記成分(A)を用いてベシクル組成物を調製することにより、成分(D)の低級一価アルコールを配合しても、経時安定性の良好なものが得られ、このベシクル組成物を配合した毛髪用化粧料を毛髪に適用した場合、素早くなじみ、毛髪内部への浸透性に優れ、有効成分の浸透感を実感でき、しっとり感を付与する効果も高い良好なものが得られる。
成分(D)の低級一価アルコールは、化粧料一般に用いられるものであれば特に制限なく用いることができ、エチルアルコール、プロピルアルコール、イソプロピルアルコール等を挙げることが出来るが、本発明においてはエチルアルコールが好ましい。The present invention also relates to a cosmetic containing the vesicle composition of the present invention. A lower monohydric alcohol can be blended as the component (D) in the cosmetic blended with the vesicle composition of the present invention.
The lower monohydric alcohol of component (D) is generally considered to be an important component in hair cosmetics in order to provide a quick drying time and a refreshing feeling during application, and contributes to good familiarity with hair. In a vesicle composition blending system, blending a lower monohydric alcohol is known to make it difficult to ensure stability over time.
However, in the present invention, by preparing a vesicle composition using the above component (A), even when the lower monohydric alcohol of component (D) is blended, a product having good temporal stability is obtained, When hair cosmetics formulated with this vesicle composition are applied to hair, they are well-familiar, have excellent penetration into the hair, can feel the penetration of active ingredients, and have a high moisturizing effect. Is obtained.
The lower monohydric alcohol of component (D) can be used without particular limitation as long as it is generally used in cosmetics, and examples thereof include ethyl alcohol, propyl alcohol, isopropyl alcohol, etc. In the present invention, ethyl alcohol Is preferred.
本発明の成分(D)の配合量は、特に限定されず、調製する化粧料の目標品質として望まれる特性、例えば、なじみ、毛髪内部への浸透性等に応じて適宜決められるが、化粧料全量中、概ね0.1〜30%が好ましく、1〜30%がより好ましく、1〜25%がさらに好ましく、5〜20%がよりさらに好ましい。 The blending amount of the component (D) of the present invention is not particularly limited, and is appropriately determined according to properties desired as the target quality of the cosmetic to be prepared, for example, familiarity, penetration into hair, and the like. In general, the total amount is preferably 0.1 to 30%, more preferably 1 to 30%, further preferably 1 to 25%, and still more preferably 5 to 20%.
本発明の化粧料の製造方法としては、特に限定されないが、例えば、上記の通り、成分(A)、(B)を、成分(C)に分散させた後、室温まで冷却させてベシクル組成物を調製すること、及び該ベシクル組成物に、成分(D)や、後述の任意成分等を配合すること、を含む方法により製造することができる。配合される任意の成分は、使用感や毛髪への更なる効果等を期待して配合される。
本発明のベシクル組成物を配合し、毛髪用化粧料とすることにより、成分(B)などの有効成分をベシクルを形成せずに配合した毛髪化粧料と比較して、経時安定性に優れ、且つ、使用時の毛髪内部への浸透性、浸透感の実感に優れた、しっとり感の付与効果の高い良好なものが得られる。
特に成分(D)を配合した化粧料においては、成分(D)は、本来、経時安定性の確保を困難なものとする傾向にある成分であるにもかかわらず、本発明のベシクル組成物を配合することで、良好な経時安定性を有し、且つ、例えば、毛髪用化粧料の態様では、毛髪に素早くなじみ、毛髪内部への浸透性、浸透感に優れ、しっとり感を付与する効果に優れたものとすることができる。Although it does not specifically limit as a manufacturing method of the cosmetics of this invention, For example, as above-mentioned, after disperse | distributing component (A) and (B) to a component (C), it is made to cool to room temperature and is a vesicle composition. Can be produced by a method comprising preparing the component (B) and blending the component (D), an optional component described later, and the like with the vesicle composition. Arbitrary ingredients to be blended are blended with the expectation of a feeling of use and further effects on hair.
By blending the vesicle composition of the present invention into a cosmetic for hair, compared to a hair cosmetic formulated with an active ingredient such as component (B) without forming a vesicle, it has excellent temporal stability, In addition, it is possible to obtain a good product having excellent moisturizing effect and excellent permeation into the hair at the time of use and a sense of penetration.
In particular, in a cosmetic containing component (D), component (D) is originally a component that tends to make it difficult to ensure stability over time, but the vesicle composition of the present invention is used. By blending, it has good temporal stability, and, for example, in the form of hair cosmetics, it quickly adapts to the hair, has excellent penetration and penetration into the hair, and gives a moist feeling It can be excellent.
本発明の化粧料へのベシクル組成物の配合量は、特に限定はなく、化粧料全量中、0.5%以上が好ましく、10%以上がより好ましい。また、本発明のベシクル組成物をそのまま100%化粧料として用いることもできる。
なお、本発明の化粧料の剤型については特に制限はないが、ベシクルを安定に維持するという観点では、外相が水系である剤型の化粧料として調製するのが好ましい。外相は、水以外に、水に溶解及び/又は分散可能な種々の剤(例えば、エチルアルコール、多価アルコール、塩類、界面活性剤等)を含んでいてもよい。The blending amount of the vesicle composition in the cosmetic of the present invention is not particularly limited, and is preferably 0.5% or more and more preferably 10% or more in the total amount of the cosmetic. In addition, the vesicle composition of the present invention can be used as it is as a 100% cosmetic.
In addition, although there is no restriction | limiting in particular about the dosage form of the cosmetics of this invention, From a viewpoint of maintaining a vesicle stably, it is preferable to prepare as cosmetics of the dosage form whose external phase is a water system. The external phase may contain various agents (for example, ethyl alcohol, polyhydric alcohol, salts, surfactants, etc.) that can be dissolved and / or dispersed in water in addition to water.
本発明のベシクル組成物及びそれを配合する化粧料には、上記成分(A)〜(C)、及び成分(D)の他に、本発明の効果を損なわない範囲で、これら以外の油剤や界面活性剤、アルコール類、金属セッケン、ゲル化剤、粉体、水溶性高分子、皮膜形成剤、樹脂、保湿剤、抗菌剤、香料、消臭剤、塩類、pH調整剤、清涼剤、紫外線吸収剤、植物抽出物、アミノ酸類、糖類、ビタミン類等の毛髪ケア用美容成分等を配合することができる。 In addition to the components (A) to (C) and the component (D), the vesicle composition of the present invention and the cosmetic composition containing the same may be used as long as the effects of the present invention are not impaired. Surfactant, alcohol, metal soap, gelling agent, powder, water-soluble polymer, film forming agent, resin, moisturizer, antibacterial agent, fragrance, deodorant, salt, pH adjuster, refreshing agent, ultraviolet ray Absorbents, plant extracts, amino acids, saccharides, vitamins and other beauty ingredients for hair care can be blended.
油剤としては、常温で液体、ペースト状及び固形状の炭化水素類、ロウ類、エステル類、脂肪酸類(上記25℃で液状の高級脂肪酸であっても、上記25℃で非液状の高級脂肪酸であってもよい)、油脂等の油性成分を使用することができる。具体的には、例えば炭化水素類、油脂類、ロウ類、硬化油類、エステル油類、脂肪酸類、シリコーン油、フッ素系油剤類、ラノリン誘導体類等が使用可能であり、より具体的には、例えば、オゾケライト、セレシン、パラフィン、パラフィンワックス、マイクロクリスタリンワックス、ミリスチン酸セチル、パルミチン酸セチル等のワックス類、ワセリン、流動パラフィン、プリスタン、ポリイソブチレン、スクワラン、スクワレン、流動パラフィン等の炭化水素類、ミツロウ、カルナウバロウ、キャンデリラロウ、鯨ロウ等のロウ類、セチルアルコール、ステアリルアルコール、セトステアリルアルコール、ベヘニルアルコール、シア脂等の固形油、牛脂、牛脚脂、牛骨脂、硬化牛脂、硬化油、タートル油、豚脂、馬脂、ミンク油、肝油、卵黄油等の動物油、ヤシ油、オリーブ油、米胚芽油、米ヌカ油、ヒマシ油、マカデミアンナッツ油、オリーブ油、アーモンド油、アボカド油、ツバキ油、ローズヒップ油、サフラワー油、サンフラワー油等の植物油脂、ホホバ油などの液状ワックス、ミリスチン酸イソプロピル、ミリスチン酸ブチル、パルミチン酸イソプロピル、オレイン酸エチル、カプリン酸セチル、ラウリン酸ヘキシル、オレイン酸デシル、オレイン酸オレイル、ラウリン酸イソステアリル、ミリスチン酸イソステアリル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、パルミチン酸2ーエチルヘキシル、パルミチン酸イソセチル、パルミチン酸イソセチル、ステアリン酸2ーエチルヘキシル、ステアリン酸イソセチル、オレイン酸イソデシル、オレイン酸オクチルドデシル、2ーエチルヘキサン酸セチル、2ーエチルヘキサン酸セトステアリル、イソステアリン酸ヘキシル、ネオペンタン酸オクチルドデシル、オクタン酸イソステアリル、イソペラルゴン酸2ーエチルヘキシル、ジメチルオクタン酸ヘキシルデシル、ジメチルオクタン酸オクチルドデシル、イソパルミチン酸2ーエチルヘキシル、イソステアリン酸イソセチル、イソステアリン酸イソステアリル、イソノナン酸イソノニル、ジオクタン酸エチレングリコール、ジカプリン酸プロピレングリコール、ジオクタン酸ネオペンチルグリコール、トリカプリン酸グリセリル、トリ2ーエチルヘキサン酸グリセリル、トリイソステアリン酸グリセリル、トリ2ーエチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン等のエステル油、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸、オレイン酸、リノール酸、アラキドン酸、ドコサヘキサエン酸(DHA)、12−ヒドロキシステアリン酸、イソステアリン酸、2−エチルヘキサン酸等の脂肪酸類、ジメチルポリシロキサン、メチルフェニルポリシロキサン等のシリコーン油、パーフルオロデカン等のフッ素系油、ラノリン、液状ラノリン、還元ラノリン、ラノリンアルコール、硬質ラノリン、酢酸ラノリン、ラノリン脂肪酸イソプロピル等のラノリン誘導体等が挙げられる。 Oils include liquid, pasty and solid hydrocarbons, waxes, esters, and fatty acids at room temperature (even if the fatty acid is liquid at 25 ° C. and non-liquid higher fatty acid at 25 ° C. And oily components such as fats and oils can be used. Specifically, for example, hydrocarbons, fats and oils, waxes, hardened oils, ester oils, fatty acids, silicone oils, fluorine-based oils, lanolin derivatives and the like can be used, and more specifically, For example, waxes such as ozokerite, ceresin, paraffin, paraffin wax, microcrystalline wax, cetyl myristate, cetyl palmitate, petrolatum, liquid paraffin, pristane, polyisobutylene, squalane, squalene, liquid paraffin hydrocarbons, Waxes such as beeswax, carnauba wax, candelilla wax, whale wax, solid oils such as cetyl alcohol, stearyl alcohol, cetostearyl alcohol, behenyl alcohol, shea fat, beef tallow, beef leg fat, beef bone fat, cured beef tallow, cured oil, Turtle oil, pork fat, horse fat, mink oil, liver oil, Animal oil such as yellow oil, palm oil, olive oil, rice germ oil, rice bran oil, castor oil, macadamia nut oil, olive oil, almond oil, avocado oil, camellia oil, rosehip oil, safflower oil, sunflower oil, etc. Liquid oils such as vegetable oils and jojoba oil, isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl oleate, cetyl caprate, hexyl laurate, decyl oleate, oleyl oleate, isostearyl laurate, isomyristate Stearyl, isocetyl myristate, octyldodecyl myristate, 2-ethylhexyl palmitate, isocetyl palmitate, isocetyl palmitate, 2-ethylhexyl stearate, isocetyl stearate, isodecyl oleate, oleic acid Cutyldecyl, 2-ethylhexanoate, cetyl 2-ethylhexanoate, hexyl isostearate, octyldodecyl neopentanoate, isostearyl octoate, 2-ethylhexyl isoperargonate, hexyldecyl dimethyloctanoate, octyldodecyl dimethyloctanoate, isopalmitate 2 -Ethylhexyl, isocetyl isostearate, isostearyl isostearate, isononyl isononanoate, ethylene glycol dioctanoate, propylene glycol dicaprate, neopentyl glycol dioctanoate, glyceryl tricaprate, glyceryl tri-2-ethylhexanoate, glyceryl triisostearate, tri-2-ethylhexane Trimethylolpropane acid, trimethylol triisostearate Ester oil such as rupropane, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, oleic acid, linoleic acid, arachidonic acid, docosahexaenoic acid (DHA), 12-hydroxystearic acid, isostearic acid, 2- Fatty acids such as ethylhexanoic acid, silicone oils such as dimethylpolysiloxane and methylphenylpolysiloxane, fluorine oils such as perfluorodecane, lanolin, liquid lanolin, reduced lanolin, lanolin alcohol, hard lanolin, lanolin acetate, lanolin fatty acid isopropyl Lanolin derivatives and the like.
界面活性剤としては、アニオン性、カチオン性、両性、非イオン性のいずれでもよく、アニオン性界面活性剤としては、ステアリン酸ナトリウムやパルミチン酸トリエタノールアミン等の脂肪酸セッケン、アルキルエーテルカルボン酸及びその塩、アミノ酸と脂肪酸の縮合等のカルボン酸塩、アルキルスルホン酸、アルケンスルホン酸塩、脂肪酸エステルのスルホン酸塩、脂肪酸アミドのスルホン酸塩、アルキルスルホン酸塩とそのホルマリン縮合物のスルホン酸塩、アルキル硫酸エステル塩、第二級高級アルコール硫酸エステル塩、アルキル及びアリルエーテル硫酸エステル塩、脂肪酸エステルの硫酸エステル塩、脂肪酸アルキロールアミドの硫酸エステル塩、ロート油等の硫酸エステル塩類、アルキルリン酸塩、エーテルリン酸塩、アルキルアリルエーテルリン酸塩、アミドリン酸塩、N−アシルアミノ酸系活性剤等が挙げられる。
カチオン性界面活性剤としては、成分(A)以外の、アルキルアミン塩、ポリアミン及びアミノアルコール脂肪酸誘導体等のアミン塩、アルキル四級アンモニウム塩、芳香族四級アンモニウム塩、ピリジニウム塩、イミダゾリウム塩等が挙げられる。
両性界面活性剤としては、ベタイン、アミノカルボン酸塩、イミダゾリン誘導体等が挙げられる。
非イオン性界面活性剤としては、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシプロピレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンプロピレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンフィトスタノールエーテル、ポリオキシエチレンフィトステロールエーテル、ポリオキシエチレンコレスタノールエーテル、ポリオキシエチレンコレステリルエーテル、ポリオキシアルキレン変性オルガノポリシロキサン、ポリオキシアルキレン・アルキル共変性オルガノポリシロキサン、ラウリン酸ジエタノールアミド、ヤシ油脂肪酸ジエタノールアミド、ヤシ油脂肪酸モノエタノールアミド、ポリオキシエチレンヤシ油脂肪酸モノエタノールアミド、ラウリン酸モノイソプロパノールアミド、ヤシ油脂肪酸モノイソプロパノールアミド、糖エーテル、糖アミド等が挙げられる。The surfactant may be any of anionic, cationic, amphoteric, and nonionic, and examples of the anionic surfactant include fatty acid soaps such as sodium stearate and triethanolamine palmitate, alkyl ether carboxylic acids and the like. Salt, carboxylate such as condensation of amino acid and fatty acid, alkyl sulfonate, alkene sulfonate, sulfonate of fatty acid ester, sulfonate of fatty acid amide, sulfonate of alkyl sulfonate and its formalin condensate, Alkyl sulfate ester, secondary higher alcohol sulfate ester, alkyl and allyl ether sulfate ester, fatty acid ester sulfate ester salt, fatty acid alkylolamide sulfate ester salt, funnel sulfate sulfate salt, alkyl phosphate , Ether phosphate, al Le allyl ether phosphates, amide phosphates, etc. N- acylamino acid-based active agents.
As cationic surfactants, other than component (A), amine salts such as alkylamine salts, polyamines and aminoalcohol fatty acid derivatives, alkyl quaternary ammonium salts, aromatic quaternary ammonium salts, pyridinium salts, imidazolium salts, etc. Is mentioned.
Examples of amphoteric surfactants include betaines, aminocarboxylates, imidazoline derivatives, and the like.
Nonionic surfactants include sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, propylene glycol fatty acid ester, polyethylene glycol fatty acid ester, sucrose fatty acid ester, polyoxyethylene alkyl ether, polyoxypropylene alkyl ether, poly Oxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene propylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene Hydrogenated castor oil, polyoxyethylene phytostanol ether, polyoxyethylene N-phytosterol ether, polyoxyethylene cholestanol ether, polyoxyethylene cholesteryl ether, polyoxyalkylene-modified organopolysiloxane, polyoxyalkylene-alkyl co-modified organopolysiloxane, lauric acid diethanolamide, coconut oil fatty acid diethanolamide, coconut oil fatty acid Examples include monoethanolamide, polyoxyethylene coconut oil fatty acid monoethanolamide, lauric acid monoisopropanolamide, coconut oil fatty acid monoisopropanolamide, sugar ether, and sugar amide.
アルコール類としては、成分(D)以外のものであればよく、グリセリン、ジグリセリン、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、ジプロピレングリコ−ル、1,3−ブチレングリコール、1,2−ペンタンジオール、ポリエチレングリコール等の多価アルコール等がある。 The alcohol may be anything other than component (D), such as glycerin, diglycerin, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, 1,2 -Polyhydric alcohols such as pentanediol and polyethylene glycol.
金属セッケンとしては、12−ヒドロキシステアリン酸アルミニウム、ステアリン酸亜鉛、ステアリン酸アルミニウム、ステアリン酸カルシウム、ステアリン酸マグネシウム、ミリスチン酸亜鉛、ミリスチン酸マグネシウム、セチルリン酸亜鉛、セチルリン酸カルシウム、セチルリン酸亜鉛ナトリウム、ラウリン酸亜鉛、ウンデシレン酸亜鉛等が挙げられる。 As the metal soap, 12-hydroxy aluminum stearate, zinc stearate, aluminum stearate, calcium stearate, magnesium stearate, zinc myristate, magnesium myristate, zinc cetyl phosphate, calcium cetyl phosphate, zinc sodium cetyl phosphate, zinc laurate And zinc undecylenate.
ゲル化剤としては、N−ラウロイル−L−グルタミン酸、α,γ−ジ−n−ブチルアミン等のアミノ酸誘導体、デキストリンパルミチン酸エステル、デキストリンステアリン酸エステル、デキストリン2−エチルヘキサン酸パルミチン酸エステル等のデキストリン脂肪酸エステル、ショ糖パルミチン酸エステル、ショ糖ステアリン酸エステル等のショ糖脂肪酸エステル、モノベンジリデンソルビトール、ジベンジリデンソルビトール等のソルビトールのベンジリデン誘導体、ジメチルベンジルドデシルアンモニウムモンモリロナイトクレー、ジメチルジオクタデシルアンモニウムモンモリロナイトクレー等の有機変性粘土鉱物等が挙げられる。 Gelling agents include amino acid derivatives such as N-lauroyl-L-glutamic acid, α, γ-di-n-butylamine, dextrins such as dextrin palmitate, dextrin stearate, dextrin 2-ethylhexanoate palmitate, etc. Fatty acid esters, sucrose fatty acid esters such as sucrose palmitate ester, sucrose stearate ester, benzylidene derivatives of sorbitol such as monobenzylidene sorbitol, dibenzylidene sorbitol, dimethylbenzyl dodecyl ammonium montmorillonite clay, dimethyl dioctadecyl ammonium montmorillonite clay, etc. Examples include organically modified clay minerals.
粉体としては、通常の化粧料に使用されるものであれば、その形状(球状、針状、板状、等)や粒子径(煙霧状、微粒子、顔料級等)、粒子構造(多孔質、無孔質等)を問わず、いずれのものも使用することができ、例えば、無機粉体としては、酸化マグネシウム、硫酸バリウム、硫酸カルシウム、硫酸マグネシウム、炭酸カルシウム、炭酸マグネシウム、タルク、合成雲母、マイカ、カオリン、セリサイト、白雲母、合成雲母、金雲母、紅雲母、黒雲母、リチア雲母、ケイ酸、無水ケイ酸、ケイ酸アルミニウム、ケイ酸マグネシウム、ケイ酸アルミニウムマグネシウム、ケイ酸カルシウム、ケイ酸バリウム、ケイ酸ストロンチウム、タングステン酸金属塩、ヒドロキシアパタイト、バーミキュライト、ハイジライト、モンモリロナイト、ゼオライト、セラミックスパウダー、第二リン酸カルシウム、アルミナ、水酸化アルミニウム、窒化ホウ素、窒化ボロン等;有機粉体としては、ポリアミドパウダー、ポリエステルパウダー、ポリエチレンパウダー、ポリプロピレンパウダー、ポリスチレンパウダー、ポリウレタン、ベンゾグアナミンパウダー、ポリメチルベンゾグアナミンパウダー、テトラフルオロエチレンパウダー、ポリメチルメタクリレートパウダー、セルロース、シルクパウダー、ナイロンパウダー、12ナイロン、6ナイロン、スチレン・アクリル酸共重合体、ジビニルベンゼン・スチレン共重合体、ビニル樹脂、尿素樹脂、フェノール樹脂、フッ素樹脂、ケイ素樹脂、アクリル樹脂、メラミン樹脂、エポキシ樹脂、ポリカーボネイト樹脂、微結晶繊維粉体、ラウロイルリジン等;有色顔料としては、酸化鉄、水酸化鉄、チタン酸鉄の無機赤色顔料、γ−酸化鉄等の無機褐色系顔料、黄酸化鉄、黄土等の無機黄色系顔料、黒酸化鉄、カーボンブラック等の無機黒色顔料、マンガンバイオレット、コバルトバイオレット等の無機紫色顔料、水酸化クロム、酸化クロム、酸化コバルト、チタン酸コバルト等の無機緑色顔料、紺青、群青等の無機青色系顔料、タール系色素をレーキ化したもの、天然色素をレーキ化したもの、及びこれらの粉体を複合化した複合粉体等;パール顔料としては、酸化チタン被覆雲母、酸化チタン被覆マイカ、オキシ塩化ビスマス、酸化チタン被覆オキシ塩化ビスマス、酸化チタン被覆タルク、魚鱗箔、酸化チタン被覆着色雲母等;金属粉末顔料としては、アルミニウムパウダー、カッパーパウダー、ステンレスパウダー等;タール色素としては、赤色3号、赤色104号、赤色106号、赤色201号、赤色202号、赤色204号、赤色205号、赤色220号、赤色226号、赤色227号、赤色228号、赤色230号、赤色401号、赤色505号、黄色4号、黄色5号、黄色202号、黄色203号、黄色204号、黄色401号、青色1号、青色2号、青色201号、青色404号、緑色3号、緑色201号、緑色204号、緑色205号、橙色201号、橙色203号、橙色204号、橙色206号、橙色207号等;天然色素としては、カルミン酸、ラッカイン酸、カルサミン、ブラジリン、クロシン等から選ばれる粉体で、これらの粉体を複合化したり、油剤やシリコーン、又はフッ素化合物で表面処理を行なった粉体でも良い。 If the powder is used in ordinary cosmetics, its shape (spherical, needle-like, plate-like, etc.), particle size (smoke-like, fine particles, pigment grade, etc.), particle structure (porous) Any inorganic powder can be used, for example, magnesium oxide, barium sulfate, calcium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, talc, synthetic mica. , Mica, kaolin, sericite, muscovite, synthetic mica, phlogopite, saucite, biotite, lithia mica, silicic acid, anhydrous silicic acid, aluminum silicate, magnesium silicate, aluminum magnesium silicate, calcium silicate, Barium silicate, strontium silicate, metal tungstate, hydroxyapatite, vermiculite, hydrite, montmorillonite, z Light, ceramic powder, dicalcium phosphate, alumina, aluminum hydroxide, boron nitride, boron nitride, etc .; organic powders include polyamide powder, polyester powder, polyethylene powder, polypropylene powder, polystyrene powder, polyurethane, benzoguanamine powder, polymethyl Benzoguanamine powder, tetrafluoroethylene powder, polymethyl methacrylate powder, cellulose, silk powder, nylon powder, 12 nylon, 6 nylon, styrene / acrylic acid copolymer, divinylbenzene / styrene copolymer, vinyl resin, urea resin, phenol Resin, fluororesin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, microcrystalline fiber powder, Lauro Luridine, etc .; as colored pigments, inorganic red pigments such as iron oxide, iron hydroxide and iron titanate, inorganic brown pigments such as γ-iron oxide, yellow inorganic oxides such as yellow iron oxide and loess, black iron oxide, Inorganic black pigments such as carbon black, inorganic purple pigments such as manganese violet and cobalt violet, inorganic green pigments such as chromium hydroxide, chromium oxide, cobalt oxide and cobalt titanate, inorganic blue pigments such as bitumen and ultramarine, tar Dye raked, natural dye raked, composite powder made by combining these powders, etc .; pearl pigments include titanium oxide-coated mica, titanium oxide-coated mica, bismuth oxychloride, titanium oxide Coated bismuth oxychloride, titanium oxide coated talc, fish scale foil, titanium oxide coated colored mica, etc .; -Powder, stainless steel powder, etc. As tar pigments, Red No. 3, Red No. 104, Red No. 106, Red No. 201, Red No. 202, Red No. 204, Red No. 205, Red No. 220, Red No. 226, Red No. 227 , Red 228, Red 230, Red 401, Red 505, Yellow 4, Yellow 5, Yellow 202, Yellow 203, Yellow 204, Yellow 401, Blue 1, Blue 2, Blue No. 201, Blue No. 404, Green No. 3, Green No. 201, Green No. 204, Green No. 205, Orange No. 201, Orange No. 203, Orange No. 204, Orange No. 206, Orange No. 207, etc .; A powder selected from acids, laccaic acid, calsamine, bradylin, crocin, etc., and these powders are compounded or surface treated with oils, silicones, or fluorine compounds It may be carried out powder.
水溶性高分子としては、アラビアゴム、トラガカント、ガラクタン、キャロブガム、グアーガム、カラヤガム、カラギーナン、ペクチン、寒天、クインスシード、アルゲコロイド、トラントガム、ローカストビーンガム、ガラクトマンナン等の植物系高分子、キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子、デンプン、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、ニトロセルロース、セルロース硫酸ナトリウム、カルボキシメチルセルロースナトリウム、結晶セルロース、セルロース末のセルロース系高分子、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子、ポリビニルメチルエーテル、カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー等のビニル系高分子、ポリオキシエチレン系高分子、ポリオキシエチレンポリオキシプロピレン共重合体系高分子、ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系高分子、ポリエチレンイミン、カチオンポリマー、ベントナイト、ラポナイト、ヘクトライト等の無機系水溶性高分子等がある。また、この中には、ポリビニルアルコールやポリビニルピロリドン等の皮膜形成剤も含まれる。 Examples of water-soluble polymers include gum-based polymers such as gum arabic, tragacanth, galactan, carob gum, guar gum, caraya gum, carrageenan, pectin, agar, quince seed, algae colloid, tant gum, locust bean gum, galactomannan, xanthan gum, dextran , Microbial polymers such as succinoglucan and pullulan, starch polymers such as starch, carboxymethyl starch and methylhydroxypropyl starch, methylcellulose, ethylcellulose, methylhydroxypropylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, nitro Cellulose, sodium cellulose sulfate, sodium carboxymethyl cellulose, crystalline cellulose, cellulose powder Cellulose polymers, sodium alginate, alginic acid polymers such as propylene glycol alginate, vinyl polymers such as polyvinyl methyl ether, carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, polyoxyethylene polymers, polyoxyethylene poly Examples include oxypropylene copolymer-based polymers, acrylic polymers such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide, and inorganic water-soluble polymers such as polyethyleneimine, cationic polymers, bentonite, laponite, and hectorite. Also included are film forming agents such as polyvinyl alcohol and polyvinyl pyrrolidone.
保湿剤としては、例えば、コンドロイチン硫酸、ヒアルロン酸、ムチン、デルマタン硫酸、ヘパリン、ケラタン硫酸等のムコ多糖類、大豆タンパク、小麦タンパク等のタンパク質、或いはこれらの誘導体、コラーゲン、エラスチン、ケラチン等が挙げられる。 Examples of the moisturizing agent include chondroitin sulfate, hyaluronic acid, mucin, dermatan sulfate, mucopolysaccharides such as heparin and keratan sulfate, proteins such as soybean protein and wheat protein, or derivatives thereof, collagen, elastin, keratin and the like. It is done.
抗菌剤としては、安息香酸、安息香酸ナトリウム、サリチル酸、石炭酸、ソルビン酸、ソルビン酸カリウム、パラオキシ安息香酸エステル、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、トリクロロカルバニリド、感光素、ビス(2−ピリジルチオ−1−オキシド)亜鉛、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。 Antibacterial agents include benzoic acid, sodium benzoate, salicylic acid, coalic acid, sorbic acid, potassium sorbate, paraoxybenzoic acid ester, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, trichlorocarbanilide, photosensitive Element, bis (2-pyridylthio-1-oxide) zinc, phenoxyethanol, isopropylmethylphenol and the like.
紫外線吸収剤としては、例えば、ベンゾフェノン系としては、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸ナトリウム、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン−5−スルホン酸ナトリウム、2,4−ジヒドロキシベンゾフェノン、2,2’,4,4’−テトラヒドロキシベンゾフェノン等が挙げられ、PABA系としては、パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラジメチルアミノ安息香酸アミル、パラジメチルアミノ安息香酸−2−エチルヘキシル、パラジヒドロキシプロピル安息香酸エチル等が挙げられ、ケイ皮酸系としては、p−メトキシケイ皮酸−2−エチルヘキシル、4−メトキシケイ皮酸−2−エトキシエチル等が挙げられ、サリチル酸系としては、サリチル酸−2−エチルヘキシル、サリチル酸フェニル、サリチル酸ホモメンチル等が挙げられ、その他、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、4−tert−ブチル−4’−メトキシジベンゾイルメタン、オキシベンゾン等が挙げられる。 Examples of the UV absorber include 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, and 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid sodium as benzophenone series. 2,2′-dihydroxy-4,4′-dimethoxybenzophenone, 2,2′-dihydroxy-4,4′-dimethoxybenzophenone-5-sulfonic acid sodium salt, 2,4-dihydroxybenzophenone, 2,2 ′, 4 , 4′-tetrahydroxybenzophenone, etc., and examples of the PABA system include paraaminobenzoic acid, ethyl paraaminobenzoate, glyceryl paraaminobenzoate, amyl paradimethylaminobenzoate, 2-dimethylhexyl paradimethylaminobenzoate, paradihydro Examples include cipropyl benzoate and the like. Cinnamic acid type includes p-methoxycinnamic acid-2-ethylhexyl, 4-methoxycinnamic acid-2-ethoxyethyl and the like. Salicylic acid type includes salicylic acid- Examples thereof include 2-ethylhexyl, phenyl salicylate, homomenthyl salicylate, and the like, and other examples include 2- (2-hydroxy-5-methylphenyl) benzotriazole, 4-tert-butyl-4′-methoxydibenzoylmethane, oxybenzone, and the like. .
pH調整剤としては、乳酸、クエン酸、グリコール酸、コハク酸、酒石酸、リンゴ酸、リン酸及びこれらの塩、炭酸カリウム、炭酸水素ナトリウム、炭酸水素アンモニウム等、清涼剤としては、L−メントール、カンフル等が挙げられる。 As a pH adjuster, lactic acid, citric acid, glycolic acid, succinic acid, tartaric acid, malic acid, phosphoric acid and their salts, potassium carbonate, sodium hydrogen carbonate, ammonium hydrogen carbonate, etc., as a refreshing agent, L-menthol, For example, camphor.
植物抽出物としては、シラカバ、ハマメリス、サルビア、ホップ、ローズマリー、バラ、オレンジ、アスパラガス、センブリ、オウゴン、スイカズラ、シソ、トウガラシ、サンショウ、イラクサ、チャ、ニンジン、サボンソウ、イブキトラノオ、ブドウ、海藻、ダイズ、ニワトコ等の植物や生薬の抽出物が挙げられる。 Plant extracts include birch, clams, salvia, hops, rosemary, roses, oranges, asparagus, assembly, red goose, honeysuckle, perilla, capsicum, salamander, nettle, tea, carrot, savanna, Ibukitorano, grape, Examples include plants such as seaweed, soybean, elderberry, and herbal extracts.
アミノ酸類としては、グリシン、プロリン、イソロイシン、ヒスチジン、アラニン、アルギニン、リジン、セリン、システイン、アセチルシステイン等が挙げられる。 Examples of amino acids include glycine, proline, isoleucine, histidine, alanine, arginine, lysine, serine, cysteine, acetylcysteine, and the like.
糖類としては、グルコース、フルクトース、ガラクトース、マンニトール、ソルビトール等が挙げられる。 Examples of the saccharide include glucose, fructose, galactose, mannitol, sorbitol and the like.
ビタミン類としては、ビタミンA及びその誘導体、ビタミンB及びその誘導体、ビタミンC及びその誘導体、ビタミンE及びその誘導体、リノレン酸及びその誘導体等のビタミンF類;フィトナジオン、メナキノン、メナジオン、メナジオール等のビタミンK類;エリオシトリン、ヘスペリジン等のビタミンP類;その他、ビオチン、カルチニン、フェルラ酸等が挙げられる。 Vitamins such as vitamin A and derivatives thereof, vitamin B and derivatives thereof, vitamin C and derivatives thereof, vitamin E and derivatives thereof, linolenic acid and derivatives thereof, and vitamins such as phytonadione, menaquinone, menadione, menadiol Ks; vitamin Ps such as eriocitrin and hesperidin; and biotin, carcinine, ferulic acid and the like.
本発明のベシクル組成物を配合した毛髪用化粧料等の化粧料は、液状、乳液状、クリーム状、ジェル状等、剤型に特に限定はなく調製することができ、例えば、ヘアローション、ヘアミルク、ヘアクリーム、ヘアトリートメント、枝毛コート剤等のアウトバスヘア製品や、リンス、ヘアパック、シャンプー等のインバスヘア製品等の毛髪用化粧料とすることができる。また、噴射剤を配合してエアゾールヘアスプレーやヘアフォームとしての実施も可能である。エチルアルコールなどの成分(D)を配合したヘアローション等の剤型においては、特に有効である。すなわち、通常、成分(B)を乳化組成物に配合した剤型では、成分(D)の配合量が多くなると、安定に配合することが困難となるが、本発明のベシクル組成物を用いた剤型では、経時安定性を確保しつつも、毛髪へのなじみに優れたものとなり、本願の構成とすることの良さが存分に発揮される。 Cosmetics such as hair cosmetics formulated with the vesicle composition of the present invention can be prepared in liquid form, emulsion form, cream form, gel form and the like without any particular limitation on the dosage form. For example, hair lotion, hair milk It can be made into cosmetics for hair such as out bath hair products such as hair creams, hair treatments, split hair coats, and in bath hair products such as rinses, hair packs, shampoos and the like. Moreover, it can also be implemented as an aerosol hair spray or hair foam by blending a propellant. It is particularly effective in a dosage form such as a hair lotion containing a component (D) such as ethyl alcohol. That is, normally, in the dosage form in which the component (B) is blended in the emulsion composition, it becomes difficult to blend stably when the blending amount of the component (D) increases, but the vesicle composition of the present invention was used. In the dosage form, while maintaining stability over time, it is excellent in familiarity with hair, and the goodness of having the configuration of the present application is fully exhibited.
成分(D)を配合した化粧料は、例えば、上記のようにして、成分(A)、(B)を、成分(C)に分散させた後、室温まで冷却させてベシクル組成物を調製すること、該組成物に成分(D)を加えることを含む方法により得られる。また、ベシクル組成物の調製同様、使用感や毛髪への更なる効果等を期待して上記任意成分を適宜その性質等に応じて加え製造することができる。 For example, as described above, the cosmetic containing component (D) is prepared by dispersing components (A) and (B) in component (C) and then cooling to room temperature to prepare a vesicle composition. And a method comprising adding component (D) to the composition. Similarly to the preparation of the vesicle composition, the above-mentioned optional components can be appropriately added according to the properties and the like in anticipation of a feeling of use and further effects on the hair.
次に実施例を挙げて、本発明を更に詳細に説明する。なお、これらは本発明を何ら限定するものではない。 EXAMPLES Next, an Example is given and this invention is demonstrated still in detail. In addition, these do not limit this invention at all.
実施例1(本発明品1及び比較品1):ベシクル組成物
下記表に示す処方及び下記製造方法により、本発明の成分(A)を用いたベシクル組成物(本発明品1)と、成分(A)の代わりに一般的な2長鎖の4級アルキルアンモニウム塩型カチオン性界面活性剤を用いたベシクル組成物(比較品1)を調製し、下記の方法によりベシクルが生成されていることを確認し、更に経時安定性をベシクルの変化(平均粒子径)で評価した。なお比較品1で用いた4級アルキルアンモニウム塩型カチオン性界面活性剤は、ジステアリルジメチルアンモニウムクロライド(「アーカード2HP−75」ライオン・アクゾ社製)である。Example 1 (Product 1 of the present invention and Comparative product 1): Vesicle composition A vesicle composition (Product 1 of the present invention) using the component (A) of the present invention according to the formulation shown in the following table and the following production method, and the components A vesicle composition (Comparative Product 1) using a general 2-long-chain quaternary alkylammonium salt type cationic surfactant instead of (A) is prepared, and the vesicle is produced by the following method. The stability over time was further evaluated by the change in vesicles (average particle diameter). The quaternary alkylammonium salt type cationic surfactant used in Comparative Product 1 is distearyldimethylammonium chloride (“Arcard 2HP-75” manufactured by Lion Akzo).
<ベシクル生成の確認>
直交ニコル下で偏光顕微鏡(オリンパス社製 DP−70)観察を行ない、ベシクルの存在(ベシクルが形成されていることの指標となるマルテーゼクロス像の存在)を確認した。また、得られたベシクル組成物(精製水10倍希釈分散物に1%リンタングステン酸水溶液を等量に加え、ネガティブ染色)について、透過型電子顕微鏡(HITACHI H−7650 加圧電圧:80kV)を用いて観察した。ベシクルの生成は、多重層構造のマルチラメラベシクルの形成を指標として確認できる。
本発明品1には、偏光顕微鏡の観察により、ベシクルが形成されていることの指標となるマルテーゼクロス像が多数観察され、また、透過型電子顕微鏡の観察により、多重層構造のマルチラメラベシクルが観察された。
本発明品1について、透過型電子顕微鏡で観察した写真を図1に、偏光顕微鏡で観察した写真を図2に示した。<Confirmation of vesicle generation>
Observation with a polarizing microscope (DP-70 manufactured by Olympus) under crossed Nicols was performed to confirm the presence of vesicles (the presence of a Maltese cross image serving as an indicator that vesicles were formed). In addition, regarding the obtained vesicle composition (1% phosphotungstic acid aqueous solution was added in an equal amount to a 10-fold diluted dispersion of purified water and negative staining), a transmission electron microscope (HITACHI H-7650, pressurized voltage: 80 kV) was used. And observed. The generation of vesicles can be confirmed with the formation of multilamellar vesicles having a multilayer structure as an index.
In the product 1 of the present invention, a large number of Maltese cross images, which are indicators of the formation of vesicles, are observed by observation with a polarizing microscope, and multilamellar vesicles having a multilayer structure are observed by observation with a transmission electron microscope. Observed.
A photograph of the product 1 of the present invention observed with a transmission electron microscope is shown in FIG. 1, and a photograph observed with a polarizing microscope is shown in FIG.
(製造方法)
A:成分1〜3を100℃に加熱溶解する。
B:成分4を90℃に加熱する。
C:BにAを添加してホモミキサーにて混合攪拌する。
D:Cを室温まで冷却して、ベシクル組成物を得た。(Production method)
A: Components 1 to 3 are heated and dissolved at 100 ° C.
B: Component 4 is heated to 90 ° C.
C: A is added to B and mixed and stirred with a homomixer.
D: C was cooled to room temperature to obtain a vesicle composition.
<経時安定性の評価>
経時安定性の評価として、下記方法により、ベシクルの平均粒子径および状態の変化を経時で測定(観察)し、それを更に下記判定基準を用いて判定した。結果は上記表に併せて示す。
(評価方法)
本発明品1、比較品1のベシクル組成物を60℃に加熱し、PCメンブラン(ポアサイズ:200nm WHATMAN社製)を装着したエクストルーダー(Avanti Polar Lipids社製)内を60℃条件下でそれぞれ10回通過させ試料を調製する。
調製した試料の平均粒子径を、調製直後、30℃のインキュベーターにて3日、及び1ヶ月間静置したものについて、動的光散乱法(Beckman Coulter N5)を用いて測定した。
更に、調製直後の試料の平均粒子径に対する1ヶ月後の試料の平均粒子径の変化(増大)の程度やベシクルの状態変化を、下記4段階判定基準を用いて判定した。
<4段階判定基準>
(判定) :(調製直後に対する1ヶ月後の平均粒子径および状態の変化)
◎(非常に良好):変化が見られない、または調製直後の平均粒子径の2倍以下
○(良好) :2倍より大きく5倍以下
△(やや不良) :5倍より大きく20倍以下
×(不良) :20倍より大きい、またはベシクルの崩壊による定量不能な状態<Evaluation of stability over time>
As the evaluation of stability over time, changes in the average particle diameter and state of vesicles were measured (observed) over time by the following method, and further determined using the following criteria. The results are shown in the above table.
(Evaluation method)
The vesicle composition of Invention product 1 and Comparative product 1 was heated to 60 ° C., and the inside of an extruder (Avanti Polar Lipids) equipped with a PC membrane (pore size: 200 nm manufactured by WHATMAN) was each 10 ° C. under 60 ° C. conditions. Pass through to prepare sample.
The average particle size of the prepared sample was measured using a dynamic light scattering method (Beckman Coulter N5) immediately after preparation for 3 days and 1 month in a 30 ° C. incubator.
Furthermore, the degree of change (increase) in the average particle size of the sample after one month relative to the average particle size of the sample immediately after preparation and the change in the state of the vesicle were determined using the following four-stage criteria.
<4 step criteria>
(Judgment): (Change in average particle diameter and state after one month with respect to immediately after preparation)
◎ (very good): no change is observed, or 2 times or less of the average particle size immediately after preparation ○ (good): 2 times to 5 times or less △ (somewhat poor): 5 times to 20 times or less × (Bad): More than 20 times or indeterminate state due to vesicle collapse
透過型電子顕微鏡及び偏光顕微鏡の観察結果(図1、2)、並びに上記表の結果から明らかな如く、成分(A)を用いた本発明品1のベシクル組成物は、良好なベシクル組成物を形成し、経時安定性においても優れたものであった。
一方、成分(A)の代わりに2長鎖の4級アルキルアンモニウム塩型カチオン性界面活性剤を用いた比較品1のベシクル組成物は、ベシクルは形成されるものの、調製直後のベシクルに比べて、1ヶ月後のベシクルの平均粒子径がひどく増大、或いはベシクルが崩壊(粒度分布のブロード化)してしまい、経時安定性の点で劣るものであった。As is clear from the observation results of the transmission electron microscope and the polarizing microscope (FIGS. 1 and 2) and the results in the above table, the vesicle composition of the product 1 of the present invention using the component (A) is a good vesicle composition. It was formed and was excellent in stability over time.
On the other hand, the vesicle composition of Comparative Product 1 using a 2-long-chain quaternary alkylammonium salt type cationic surfactant in place of the component (A), although vesicles were formed, compared with the vesicles immediately after preparation. The average particle diameter of the vesicles after one month was greatly increased, or the vesicles were disintegrated (the particle size distribution was broadened), which was inferior in terms of stability over time.
実施例2(本発明品2〜4):ベシクル組成物
上記本発明品1の調製において成分(A)として使用した、ジココイルエチルヒドロキシエチルモニウムメトサルフェート(80%)プロピレングリコール溶液を、ジパルミトイルエチルヒドロキシエチルモニウムメトサルフェート(90%)イソプロパノール溶液に代えた以外、同様にしてベシクル組成物を調製した(以下、これを「本発明品2」とする)。また、本発明品1の(A)/(B)のモル比7/3を、1/4にかえた以外は同様にして、ベシクル組成物を調製した(以下、これを「本発明品3」とする)。さらに、本発明品3に、イソステアリン酸を添加して同様にベシクル組成物を調製した(以下、これを「本発明品4」とする)。実施例1と同様に、ベシクルの状態変化を評価した。処方及び結果を下記表2に示す。Example 2 (Products 2 to 4 of the present invention): Vesicle composition A solution of dicocoylethylhydroxyethylmonium methosulfate (80%) propylene glycol used as component (A) in the preparation of the product 1 of the present invention was converted to dipalmitoyl. A vesicle composition was prepared in the same manner except that the ethylhydroxyethylmonium methosulfate (90%) isopropanol solution was used (hereinafter referred to as "Product 2 of the present invention"). Further, a vesicle composition was prepared in the same manner except that the molar ratio 7/3 of (A) / (B) of the product 1 of the present invention was changed to 1/4 (hereinafter referred to as “the product 3 of the present invention”). ”). Furthermore, isostearic acid was added to the product 3 of the present invention to prepare a vesicle composition (hereinafter referred to as “product 4 of the present invention”). In the same manner as in Example 1, changes in the state of vesicles were evaluated. The formulation and results are shown in Table 2 below.
(本発明品2〜4の製造方法)
A:成分1〜4を100℃に加熱溶解する。
B:成分5を90℃に加熱する。
C:BにAを添加してホモミキサーにて混合攪拌する。
D:Cを室温まで冷却して、ベシクル組成物を得た。(Manufacturing method of the present invention products 2 to 4)
A: Components 1 to 4 are heated and dissolved at 100 ° C.
B: Component 5 is heated to 90 ° C.
C: A is added to B and mixed and stirred with a homomixer.
D: C was cooled to room temperature to obtain a vesicle composition.
<毛髪内部への浸透性の評価(毛髪断面の観察)>
実施例3(本発明品5及び比較品2〜4)
次に、下記表に示す処方及び下記製造方法により、蛍光性のマーカー;ピレン(pyrene)含有ベシクル組成物(試料)を調製し、下記方法により、毛髪内部への浸透性を評価した。<Evaluation of penetration into hair (observation of hair cross section)>
Example 3 (Product 5 of the present invention and Comparative products 2 to 4)
Next, a fluorescent marker; pyrene-containing vesicle composition (sample) was prepared by the formulation shown in the following table and the following production method, and the penetration into the hair was evaluated by the following method.
(製造方法)
A:成分1〜5を100℃に加熱溶解する。
B:成分6を90℃に加熱する。
C:BにAを添加してホモミキサーにて混合攪拌する。
D:Cを室温まで冷却し試料を調製した。(Production method)
A: Components 1 to 5 are dissolved by heating at 100 ° C.
B: Component 6 is heated to 90 ° C.
C: A is added to B and mixed and stirred with a homomixer.
D: C was cooled to room temperature to prepare a sample.
(評価方法)
(1)上記表及び上記製造方法により調製したピレン含有ベシクル組成物等の試料に毛束(毛髪)を12時間浸漬
(2)(1)から毛髪を取り出して樹脂包埋し、ミクロトームで毛髪横断面の切片作製
(3)(2)の毛髪横断面の切片を蛍光顕微鏡で観察(蛍光顕微鏡の観察条件:励起フィルタ:330−385nm 蛍光フィルタ:420nm 露光時間:0.20S)。得られたベシクル組成物について、蛍光性のマーカーであるピレンの毛髪内部への浸透性を見ることで、ベシクル組成物(コレステロール)の毛髪内部への浸透性の評価とした。(Evaluation method)
(1) A hair bundle (hair) is immersed in a sample such as the pyrene-containing vesicle composition prepared by the above table and the above manufacturing method for 12 hours. (2) The hair is taken out from (1), embedded in resin, and crossed by a microtome. Surface section preparation (3) The section of the hair cross section of (2) was observed with a fluorescence microscope (observation conditions of the fluorescence microscope: excitation filter: 330-385 nm, fluorescence filter: 420 nm, exposure time: 0.20 S). With respect to the obtained vesicle composition, the penetrability of pyrene, which is a fluorescent marker, into the hair was evaluated to evaluate the permeability of the vesicle composition (cholesterol) into the hair.
上記(3)の蛍光顕微鏡で観察した結果(写真)を図3に示す。
図3の写真のうち、図3−1、図3−2、図3−3、図3−4は、それぞれ、本発明品5、比較品2(蛍光マーカー;ピレン非添加)、比較品3、比較品4の試料に浸漬した毛髪の断面図である。
図3の写真において、青白く光っている部分(白黒図面では白く見える部分)は、蛍光性マーカーであるピレンが存在していることを示している。
図3の写真より、ピレンを配合していない比較品2に浸漬した図3−2は殆ど何も見えず(毛髪断面の形状が分からず)、ピレンを炭化水素油に添加しただけの比較品3に浸漬した図3−3は、ぼんやりと毛髪断面の状態が分かる程度に青く(白黒図面では白く)見えるだけで、成分(A)の代わりに2長鎖の4級アルキルアンモニウム塩型カチオン性界面活性剤を用いた比較品4に浸漬した図3−4は、比較品3に浸漬したものよりはやや青白さ(白黒図面では白さ)が強く毛髪断面の状態が分かるものの、然程違いがないことが分かる。
これに対し、本発明品5のベシクル組成物に浸漬した図3−1は、上記比較試験例に浸漬したものに比べ、毛髪断面全体が明らかに青白く(白黒図面では白く)、毛髪の中心部までよく光っている。
すなわち、成分(A)を用いて調製した本発明品5のベシクル組成物は、毛髪内部への浸透性が非常に高いことが分かる。
これは、成分(A)が、その親油基内に有するエステル結合により微視的な極性を有するため、ベシクル膜の膜流動性(ベシクル膜の変形性)に優れたものとなり、毛髪内部に浸透し易く、そのため高い浸透性が発揮されたものと考えられる。The result (photograph) observed with the fluorescence microscope of (3) is shown in FIG.
3, FIG. 3-1, FIG. 3-2, FIG. 3-3, and FIG. 3-4 show the product 5 of the present invention, the comparative product 2 (fluorescent marker; no pyrene added), and the comparative product 3 respectively. It is sectional drawing of the hair immersed in the sample of the comparative product 4. FIG.
In the photograph of FIG. 3, the portion that is shining blue (the portion that appears white in the black-and-white drawing) indicates that pyrene, which is a fluorescent marker, is present.
From the photograph of FIG. 3, FIG. 3-2 immersed in the comparative product 2 containing no pyrene hardly shows anything (the shape of the hair cross section is not known), and the comparative product is simply added to the hydrocarbon oil. Fig. 3-3 immersed in 3 only looks blue (approximally white in black and white drawings) so that the state of the hair cross-section can be clearly understood, and instead of component (A), it is a quaternary alkylammonium salt type cationic compound having two long chains 3-4 immersed in comparative product 4 using a surfactant is slightly different from the one immersed in comparative product 3, although the bluish whiteness (whiteness in black and white drawings) is stronger and the state of the hair cross section can be understood. You can see that there is no.
On the other hand, FIG. 3-1, immersed in the vesicle composition of the product 5 of the present invention, is clearly pale in color as a whole hair cross section (white in the black-and-white drawing) compared to the one immersed in the above comparative test example. It is shining well.
That is, it can be seen that the vesicle composition of the product 5 of the present invention prepared using the component (A) has very high permeability into the hair.
This is because the component (A) has a microscopic polarity due to the ester bond in the lipophilic group, and thus the membrane fluidity of the vesicle membrane (deformability of the vesicle membrane) is excellent, It is thought that it penetrated easily and therefore high permeability was exhibited.
(水分保持能に関する実験条件と結果)
また、上記で調製した本発明品5を毛髪中に浸透させ、毛髪中の結合水比率の定量を行った。その結果を図4に示す。この効果は、毛髪用化粧料(ヘアローション)の毛髪に対するしっとり感付与の効果に関連するものである。なお、測定には近赤外分光光度計「Spectrum400」(Perkin Elmer社製)を用い、被験サンプルとしては、同一人毛からなる毛束(約5g)を利用した。具体的には、以下の通りである。
本発明品5を毛束に塗布し、よく乾燥させて毛髪サンプルを得た。比較対照品として、同一人毛の毛束(約5g)に精製水を塗布し、良く乾燥させた参照用毛髪サンプルを得た。近赤外分光測定は、5350cm−1〜4950cm−1の範囲で行い、得られたスペクトルのピーク面積を、下記式1に適用することで、毛髪中の結合水比率を求めた。
式1
結合水比率(%)={ピーク面積1/(ピーク面積1+ピーク面積2)}×100
ピーク面積1(5150cm−1〜4950cm−1):強い結合水(毛髪から水分蒸散が起こりにくいことを意味する)
ピーク面積2(5350cm−1〜5150cm−1):弱い結合水(毛髪から水分蒸散が起こりやすいことを意味する)(Experimental conditions and results regarding water retention capacity)
Further, the product 5 of the present invention prepared above was permeated into the hair, and the binding water ratio in the hair was quantified. The result is shown in FIG. This effect relates to the effect of imparting a moist feeling to the hair of a hair cosmetic (hair lotion). For the measurement, a near-infrared spectrophotometer “Spectrum 400” (manufactured by Perkin Elmer) was used, and a hair bundle (about 5 g) made of the same human hair was used as a test sample. Specifically, it is as follows.
The product 5 of the present invention was applied to a hair bundle and dried well to obtain a hair sample. As a comparative control product, purified water was applied to a hair bundle (about 5 g) of the same human hair, and a well-dried reference hair sample was obtained. Near-infrared spectroscopic measurement was performed in the range of 5350 cm −1 to 4950 cm −1 , and the peak area of the obtained spectrum was applied to the following formula 1 to determine the bound water ratio in the hair.
Formula 1
Bonded water ratio (%) = {peak area 1 / (peak area 1 + peak area 2)} × 100
Peak area 1 (5150 cm −1 to 4950 cm −1 ): Strong bound water (means that moisture transpiration hardly occurs from hair)
Peak area 2 (5350 cm −1 to 5150 cm −1 ): Weak bound water (means that water is likely to evaporate from the hair)
図4に示す結果から、精製水を塗布した参照用毛髪サンプルと比較して、本発明品5を塗布した毛髪サンプルは、その毛髪中の結合水比率が、有意に増加していることが理解できる。このことは、本発明品5の塗布により毛髪の水分保持能が向上したことを示しており、即ち、この効果が毛髪に対するしっとり感の付与の起因であることが理解できる。 From the results shown in FIG. 4, it is understood that the binding water ratio in the hair of the hair sample applied with the product 5 of the present invention is significantly increased compared to the reference hair sample applied with purified water. it can. This indicates that the moisture retention ability of the hair has been improved by applying the product 5 of the present invention, that is, it can be understood that this effect is due to the moist feeling imparted to the hair.
実施例4
(ベシクル組成物の経時安定性評価)
ジパルミトイルエチルヒドロキシエチルモニウムメトサルフェート(DEQ)1質量部を水99質量部に分散させて得られたベシクル試料1(即ち、DEQ/CL=10/0(モル比率))、DEQ、及びコレステロール(CL)とをモル比率7/3で予備混合し、そのうちの1質量部を水99質量部に分散させて得られたベシクル試料2(即ち、DEQ/CL=7/3(モル比率))、ジステアリルジメチルアンモニウムクロライド(DSAC)1質量部を水99質量部に分散させて得られたベシクル試料3(即ち、DSAC/CL=10/0(モル比率))、並びにDSAC、及びCLとをモル比率7/3で予備混合し、そのうちの1質量部を水99質量部に分散させて得られたベシクル試料4(即ち、DSAC/CL=7/3(モル比率))をそれぞれ調製した。各試料の調製に用いた試薬は、実施例1で用いた試薬とそれぞれ同一である。Example 4
(Stability evaluation of vesicle composition over time)
Vesicle sample 1 obtained by dispersing 1 part by mass of dipalmitoylethylhydroxyethylmonium methosulphate (DEQ) in 99 parts by mass of water (ie, DEQ / CL = 10/0 (molar ratio)), DEQ, and cholesterol ( CL) and a vesicle sample 2 obtained by dispersing 1 part by mass in 99 parts by mass of water (that is, DEQ / CL = 7/3 (molar ratio)), A vesicle sample 3 obtained by dispersing 1 part by mass of distearyldimethylammonium chloride (DSAC) in 99 parts by mass of water (that is, DSAC / CL = 10/0 (molar ratio)), DSAC, and CL were added in moles. Vesicle sample 4 (ie, DSAC / CL = 7/3 (molar ratio) obtained by premixing at a ratio of 7/3 and dispersing 1 part by weight in 99 parts by weight of water. )) Was prepared, respectively. The reagents used for preparing each sample are the same as the reagents used in Example 1, respectively.
各試料の調製においては、各成分をテトラヒドロフラン(THF)に溶解後、ロータリーエバポレーターにて溶媒(THF)を除去し、80℃も加熱し、精製水を注ぎ、プローブ式超音波照射機「VCX130PB」(SONIC&MATERIALS社製)を用い、30分間の超音波照射を行って調製した。得られた各試料の固形分濃度は1質量%に統一した。得られたベシクル分散液をエクストルーダーにて複数回処理し、平均粒子径を均一にしてから平均粒子径の経時変化を観察した。
また各試料を偏光顕微鏡で観察し、初期においてはマルテローゼクロス像を確認し、即ち、ベシクルが形成されていることを確認した。In preparing each sample, each component was dissolved in tetrahydrofuran (THF), then the solvent (THF) was removed with a rotary evaporator, heated to 80 ° C., purified water was poured, and a probe-type ultrasonic irradiator “VCX130PB” (Manufactured by SONIC & MATERIALS) was prepared by ultrasonic irradiation for 30 minutes. The solid content concentration of each obtained sample was unified to 1% by mass. The obtained vesicle dispersion was treated with an extruder a plurality of times to make the average particle size uniform, and the change in the average particle size over time was observed.
In addition, each sample was observed with a polarizing microscope, and at the initial stage, a Martelose cross image was confirmed, that is, it was confirmed that a vesicle was formed.
結果を図5及び図6にそれぞれ示す。
図5に示す結果から、本発明に係る成分(A)の一例であるジパルミトイルエチルヒドロキシエチルモニウムメトサルフェート(DEQ)を含むベシクル組成物では、コレステロールを添加した試料2のほうが、コレステロールを添加していない試料1と比較して、ベシクル粒子の径が変動せず、経時安定性に優れていることが理解できる。
一方、図6に示す結果から、エステル結合を含まない長鎖アルキル基を有するジステアリルジメチルアンモニウムクロライド(DSAC)を含むベシクル組成物では、コレステロールの添加により、試料4の経時安定性が顕著に低下したことが理解できる。The results are shown in FIGS. 5 and 6, respectively.
From the results shown in FIG. 5, in the vesicle composition containing dipalmitoylethylhydroxyethylmonium methosulphate (DEQ) which is an example of the component (A) according to the present invention, the sample 2 to which cholesterol was added added cholesterol. It can be understood that the diameter of the vesicle particles does not vary and the stability over time is excellent as compared with the sample 1 that is not.
On the other hand, from the results shown in FIG. 6, in the vesicle composition containing distearyldimethylammonium chloride (DSAC) having a long-chain alkyl group not containing an ester bond, the time-dependent stability of Sample 4 is significantly reduced by the addition of cholesterol. I can understand.
また、上記で調製したベシクル試料1(即ち、DEQ/CL=10/0(モル比率))、及びベシクル試料2(即ち、DEQ/CL=7/3(モル比率))、については、示差走査熱量を測定したので、その結果を図7に示す。なお、測定には、「DSC7020」(SII社)を用い、参照物質には酸化アルミニウム粉末、昇温条件は1℃/minとして、30℃から110℃の範囲で測定を行った。
図7に示すDSC曲線から、ベシクル試料1において35℃から45℃付近で観察されたDEQのゲル−液晶転移に伴う吸熱ピーク(図中丸印で囲んだ部分)が、ベシクル試料2においては消失していることから、DEQとCLが分子レベルで相溶し、熱的に安定なゲル−液晶中間体が形成されたことが示される。The vesicle sample 1 prepared above (ie, DEQ / CL = 10/0 (molar ratio)) and the vesicle sample 2 (ie, DEQ / CL = 7/3 (molar ratio)) are differentially scanned. Since the calorific value was measured, the result is shown in FIG. In addition, "DSC7020" (SII company) was used for the measurement, the measurement was performed in the range of 30 ° C to 110 ° C with aluminum oxide powder as the reference substance and the temperature raising condition of 1 ° C / min.
From the DSC curve shown in FIG. 7, the endothermic peak (the part surrounded by a circle in the figure) accompanying the gel-liquid crystal transition of DEQ observed in the vesicle sample 1 from 35 ° C. to 45 ° C. disappears in the vesicle sample 2. This indicates that DEQ and CL are compatible at the molecular level, and a thermally stable gel-liquid crystal intermediate is formed.
実施例5(本発明品6〜10及び比較品5〜7):毛髪用化粧料(ヘアローション)
下記表に示す下記処方及び下記の製造方法により毛髪用化粧料を調製し、(イ)経時安定性、(ロ)毛髪へのなじみ、(ハ)毛髪への浸透感、(ニ)しっとり感の付与に関して下記の方法により評価した。その結果も併せて下記表に示す。Example 5 (Invention Products 6 to 10 and Comparative Products 5 to 7): Hair Cosmetic (Hair Lotion)
Prepare hair cosmetics by the following formulation and the following manufacturing method shown in the following table, and (i) stability over time, (b) familiarity with hair, (c) penetration into hair, and (d) moist feeling. The application was evaluated by the following method. The results are also shown in the following table.
(製造方法)
A:成分1〜5を100℃に加熱溶解する。
B:成分8を90℃に加熱する。
C:BにAを添加してホモミキサーにて混合攪拌する。
D:Cを室温まで冷却する。
E:Dに6、7を加え、毛髪用化粧料(ヘアローション)を得た。(Production method)
A: Components 1 to 5 are dissolved by heating at 100 ° C.
B: Component 8 is heated to 90 ° C.
C: A is added to B and mixed and stirred with a homomixer.
D: Cool C to room temperature.
E: 6 and 7 were added to D to obtain a cosmetic for hair (hair lotion).
(評価方法)
(イ)経時安定性
上記実施例1と同じ方法により、経時安定性を判定(評価)した。(Evaluation method)
(I) Stability over time Stability over time was determined (evaluated) by the same method as in Example 1 above.
(評価方法)
(ロ)毛髪へのなじみ
(ハ)毛髪内部への浸透感
(ニ)しっとり感の付与
専門パネル10名による使用テストを行い、(ロ)毛髪へのなじみ、(ハ)毛髪内部への浸透感、(ニ)しっとり感の付与について、それぞれ下記5段階評価基準にて絶対評価し、各試料ごとのパネル全員の評点からその平均値を算出し、それを更に下記4段階判定基準により判定した。
<5段階評価基準>
(評点) : (評価)
5点:非常に良好/非常に強く感じる
4点:良好/強く感じる
3点:普通/やや感じる
2点:やや不良/あまり感じない
1点:不良/感じない
<4段階判定基準>
(判定) : (評点の平均点)
◎ : 4.5点を超える
○ : 3.5点を超え4.5点未満
△ : 1.5点を超え3.5点未満
× : 1.5点以下(Evaluation method)
(B) Familiarity with hair (c) Penetration feeling inside hair (d) Moisturizing test A ten-special panel test was conducted to (b) Familiarity with hair, (c) Penetration feeling inside hair (D) The moist feeling was evaluated by absolute evaluation according to the following five-stage evaluation criteria, the average value was calculated from the scores of all the panels for each sample, and further determined according to the following four-step evaluation criteria.
<5-level evaluation criteria>
(Score): (Evaluation)
5 points: feels very good / very strong 4 points: feels good / strong 3 points: normal / feels slightly 2 points: slightly bad / not very felt 1 point: bad / not felt <4-step criteria>
(Judgment): (Average score)
◎: More than 4.5 points ○: More than 3.5 points and less than 4.5 points △: More than 1.5 points and less than 3.5 points ×: 1.5 points or less
上記表に示す結果から明らかな如く、本発明品6〜10の毛髪用化粧料はいずれも、比較品5〜7の毛髪用化粧料に比べ、経時安定性に優れ、毛髪に塗布すると素早くなじみ、化粧料が毛髪内部に浸透していく浸透感を実感でき、しっとり感の付与に優れたものであった。また、中でも、本来は経時安定性の確保を困難なものとする傾向にある成分(D)を配合した本発明品9、10は、毛髪へのなじみ、毛髪内部への浸透感、しっとり感の付与等、使用感に優れるだけでなく、十分な経時安定性を示すもので、特に成分(D)としてエチルアルコールを配合した本発明品9は、これを塗布すると毛髪に素早くすっとなじみ、極めて浸透感に優れるものであった。
一方、一般的な2長鎖の4級アルキルアンモニウム塩型カチオン性界面活性剤を用いた比較品5、7は、成分(B)の代わりにステアリルアルコールを配合した比較品6も含め、いずれも経時安定性が悪く、毛髪内部への浸透感にも劣るものであった。
また、成分(B)の代わりに高級アルコールを用いた比較品4は、成分(A)を用いても、経時安定性、及び毛髪内部への浸透感が悪く、しっとり感に付与に劣るものであった。As is apparent from the results shown in the above table, all of the hair cosmetics of the present invention products 6 to 10 are superior in stability over time compared to the hair cosmetic products of comparative products 5 to 7, and quickly become familiar when applied to hair. It was possible to realize a permeation feeling that the cosmetic penetrated into the hair and was excellent in imparting a moist feeling. In particular, the products 9 and 10 of the present invention, which are blended with the component (D) that tends to make it difficult to ensure stability over time, are familiar with hair, have a penetrating feeling inside the hair, and have a moist feeling. In addition to excellent feeling of use, such as imparting, it exhibits sufficient stability over time, and in particular, the product 9 of the present invention containing ethyl alcohol as the component (D) quickly and smoothly blends into the hair when applied and is extremely penetrating. It was excellent in feeling.
On the other hand, comparative products 5 and 7 using a general 2-long-chain quaternary alkyl ammonium salt type cationic surfactant include comparative product 6 containing stearyl alcohol instead of component ( B ). The stability over time was poor and the penetration into the hair was poor.
Moreover, the comparative product 4 using a higher alcohol instead of the component (B) is inferior in imparting a moist feeling with poor temporal stability and a sense of penetration into the hair even when the component (A) is used. there were.
実施例6:ベシクル組成物
(成分) (%)
1.ジパルミトイルヒドロキシエチルモニウムメトサルフェート
90%イソプロパノール溶液 *4 3
2.フィトステロール *5 0.36
3.1,2−ペンタンジオール 5
4.精製水 残量
*4:DEHYQUART AU56/G(コグニス社製 分子量:751)
*5:フィトステロール(エーザイ社製 平均分子量:409.4)Example 6: Vesicle composition (component) (%)
1. Dipalmitoylhydroxyethylmonium methosulfate 90% isopropanol solution * 4 3
2. Phytosterol * 5 0.36
3. 1,2-pentanediol 5
4). Purified water remaining amount * 4: DEHYQUAT AU56 / G (Molecular weight: 751 manufactured by Cognis)
* 5: Phytosterol (Eisai's average molecular weight: 409.4)
(製造方法)
A:成分1〜3を100℃に加熱溶解する。
B:成分4を90℃に加熱する。
C:BにAを添加してホモミキサーにて乳化する。
D:Cを室温まで冷却して、ベシクル組成物を得た。(Production method)
A: Components 1 to 3 are heated and dissolved at 100 ° C.
B: Component 4 is heated to 90 ° C.
C: A is added to B and emulsified with a homomixer.
D: C was cooled to room temperature to obtain a vesicle composition.
実施例6のベシクル組成物は、実施例1と同様の方法で評価したところ、良好なベシクルが形成され、マルテーゼクロス像が観察された。また、経時での平均粒子径の変化も少なく安定性にも優れたものであった。
尚、実施例6のベシクル組成物において、成分(A)と成分(B)のモル比(A)/(B)は(A)/(B)モル比は4であった。The vesicle composition of Example 6 was evaluated in the same manner as in Example 1. As a result, good vesicles were formed and a Maltese cross image was observed. In addition, the change in average particle diameter with time was small, and the stability was excellent.
In the vesicle composition of Example 6, the molar ratio (A) / (B) of component (A) to component (B) was 4 (A) / (B).
実施例7:毛髪用化粧料(ヘアミルク)
(成分) (%)
1.ジココイルエチルヒドロキシエチルモニウムメトサルフェート
80%プロピレングリコール溶液 *1 3
2.コレステロール *3 0.75
3.オリーブ油 0.75
4.プロピレングリコール 5
5.精製水 残量Example 7: Hair cosmetic (hair milk)
(Ingredient) (%)
1. Dicocoylethylhydroxyethylmonium methosulfate 80% propylene glycol solution * 1 3
2. Cholesterol * 3 0.75
3. Olive oil 0.75
4). Propylene glycol 5
5. Purified water remaining
(製造方法)
A:成分1、2、及び3を100℃に加熱溶解する。
B:成分5を90℃に加熱する。
C:BにAを添加してホモミキサーにて混合攪拌する。
D:Cを室温まで冷却してベシクル組成物を得る。
E:Dに成分4を添加して室温まで冷却する。
F:Eを容器に入れて毛髪用化粧料(ヘアミルク)を得た。(Production method)
A: Components 1, 2, and 3 are heated and dissolved at 100 ° C.
B: Component 5 is heated to 90 ° C.
C: A is added to B and mixed and stirred with a homomixer.
D: C is cooled to room temperature to obtain a vesicle composition.
E: Add component 4 to D and cool to room temperature.
F: E was put in a container to obtain a cosmetic for hair (hair milk).
実施例7の毛髪用化粧料(ヘアミルク)について、実施例1、実施例3と同様の方法にて評価したところ、マルテーゼクロス像が観察され、良好なベシクルが形成されていることがわかった。また、経時安定性、毛髪へのなじみ、浸透感、しっとり感の付与の全てにおいて優れたものであった。
尚、実施例7の毛髪用化粧料(ヘアミルク)において、成分(A)と成分(B)のモル比(A)/(B)は1.8であった。About the cosmetics for hair (hair milk) of Example 7, when evaluated by the same method as Example 1 and Example 3, a Maltese cross image was observed and it turned out that the favorable vesicle is formed. Moreover, it was excellent in all of the stability over time, the familiarity with hair, the penetrating feeling and the moist feeling.
In addition, in the cosmetic for hair (hair milk) of Example 7, molar ratio (A) / (B) of a component (A) and a component (B) was 1.8.
実施例8:毛髪用化粧料(ヘアローション)
(成分) (%)
1.ジココイルエチルヒドロキシエチルモニウムメトサルフェート
80%プロピレングリコール溶液 *1 3
2.コレステロール *3 0.36
3.精製水 30
4.ジメチルポリシロキサン(100CS) 0.5
5.イソステアリン酸 0.54
6.プロピレングリコール 5
7.エチルアルコール 5
8.精製水 残量
9.香料 0.1Example 8: Hair cosmetic (hair lotion)
(Ingredient) (%)
1. Dicocoylethylhydroxyethylmonium methosulfate 80% propylene glycol solution * 1 3
2. Cholesterol * 3 0.36
3. Purified water 30
4). Dimethylpolysiloxane (100CS) 0.5
5. Isostearic acid 0.54
6). Propylene glycol 5
7). Ethyl alcohol 5
8). Purified water remaining 9. Fragrance 0.1
(製造方法)
A:成分1、2、及び5を100℃に加熱溶解する。
B:成分3を90℃に加熱する。
C:BにAを添加してホモミキサーにて混合攪拌する。
D:Cを室温まで冷却しベシクル組成物を得る。
E:Dに成分4、6を加え均一に混合する。
F:Eに成分7〜9を加え均一に混合する。
G:Fを容器に充填して毛髪用化粧料(ヘアローション)を得た。(Production method)
A: Components 1, 2, and 5 are heated and dissolved at 100 ° C.
B: Component 3 is heated to 90 ° C.
C: A is added to B and mixed and stirred with a homomixer.
D: C is cooled to room temperature to obtain a vesicle composition.
E: Components 4 and 6 are added to D and mixed uniformly.
F: Components 7 to 9 are added to E and mixed uniformly.
G: F was filled in a container to obtain a hair cosmetic (hair lotion).
実施例8の毛髪用化粧料(ヘアローション)について、実施例1、実施例3と同様の方法にて評価したところ、良好なマルテーゼクロス像が観察され、良好なベシクルが形成されていることがわかった。また、経時安定性、毛髪へのなじみ、浸透感、しっとり感の付与の全てにおいて優れたものであった。
尚、実施例8の毛髪用化粧料において、成分(A)と成分(B)のモル比(A)/(B)は3.8であった。About the cosmetics for hair (hair lotion) of Example 8, when evaluated by the same method as Example 1 and Example 3, a favorable Maltese cloth image was observed and it was confirmed that a favorable vesicle was formed. all right. Moreover, it was excellent in all of the stability over time, the familiarity with hair, the penetrating feeling and the moist feeling.
In the hair cosmetic composition of Example 8, the molar ratio (A) / (B) of the component (A) to the component (B) was 3.8.
実施例9:毛髪用化粧料(ヘアエッセンス)
(成分) (%)
1.本発明品1のベシクル組成物 90
2.精製水 4.6
3.グリセリン 5
4.ソルビトール 0.1
5.グリシン 0.1
6.海藻エキス 0.1
7.香料 0.1Example 9: Hair cosmetic (hair essence)
(Ingredient) (%)
1. Inventive product 1 vesicle composition 90
2. Purified water 4.6
3. Glycerin 5
4). Sorbitol 0.1
5. Glycine 0.1
6). Seaweed extract 0.1
7). Fragrance 0.1
(製造方法)
A:成分1、2を室温にて均一に混合する。
B:Aに成分3〜6、及び7を加えて均一に混合する。
C:Bを容器に充填して毛髪用化粧料(ヘアエッセンス)を得た。(Production method)
A: Components 1 and 2 are mixed uniformly at room temperature.
B: Components 3 to 6 and 7 are added to A and mixed uniformly.
C: B was filled in a container to obtain a hair cosmetic (hair essence).
実施例9の毛髪用化粧料(ヘアエッセンス)について、実施例3と同様の方法にて評価したところ、経時安定性、毛髪へのなじみ、浸透感、しっとり感の付与の全てにおいて優れたものであった。 The hair cosmetic of Example 9 (hair essence) was evaluated in the same manner as in Example 3. As a result, it was excellent in all of the stability over time, the familiarity with the hair, the penetration feeling, and the moist feeling. there were.
実施例10:毛髪用化粧料(ヘアミスト)
(成分) (%)
1.実施例6のベシクル組成物 1
2.加水分解コラーゲン溶液 0.3
3.精製水 残量Example 10: Hair cosmetic (hair mist)
(Ingredient) (%)
1. Vesicle composition of Example 6 1
2. Hydrolyzed collagen solution 0.3
3. Purified water remaining
(製造方法)
A:成分1〜3を室温にて均一に混合する。
B:Aをミスト容器に充填して毛髪用化粧料を得た。(Production method)
A: Components 1 to 3 are mixed uniformly at room temperature.
B: A cosmetic material for hair was obtained by filling A into a mist container.
実施例10の毛髪用化粧料(ヘアミスト)について、実施例3と同様の方法にて評価したところ、経時安定性、毛髪へのなじみ、浸透感、しっとり感の付与の全てにおいて優れたものであった。 The hair cosmetic composition of Example 10 (hair mist) was evaluated in the same manner as in Example 3. The hair cosmetic composition was excellent in all of the stability over time, the familiarity with the hair, the penetrating feeling, and the moist feeling. It was.
実施例11:ボディ用保湿化粧料
(成分) (%)
1.本発明品4のベシクル組成物 0.5
2.L−テアニン 0.1
3.ヒアルロン酸ナトリウム(1%水溶液) 5.0
4.精製水 残量Example 11: Moisturizing cosmetic for body (ingredient) (%)
1. Vesicle composition of product 4 of the present invention 0.5
2. L-theanine 0.1
3. Sodium hyaluronate (1% aqueous solution) 5.0
4). Purified water remaining
(製造方法)
A:成分1〜4を室温にて均一に混合する。
B:Aを容器に充填してボディ用保湿化粧料を得た。(Production method)
A: Components 1 to 4 are uniformly mixed at room temperature.
B: A container was filled with A to obtain a moisturizing cosmetic for body.
実施例11のボディ用保湿化粧料について、実施例3と同様の方法にて評価したところ、経時安定性、肌へのなじみ、浸透感、しっとり感の付与の全てにおいて優れたものであった。 The body moisturizing cosmetic of Example 11 was evaluated in the same manner as in Example 3. As a result, it was excellent in all of the stability over time, the familiarity with the skin, the penetrating feeling and the moist feeling.
Claims (4)
(A)ジココイルエチルヒドロキシエチルモニウムメトサルフェート、及びジパルミトイルエチルヒドロキシエチルモニウムメトサルフェートからなる群より選択されるカチオン性界面活性剤
(B)コレステロール及び/又はフィトステロール
(C) 水
を含有することを特徴とし、成分(A)と成分(B)のモル比(A)/(B)が、100/1〜1/4の範囲内にある、ベシクル組成物。 The following components (A) to (C),
(A) a cationic surfactant selected from the group consisting of dicocoylethylhydroxyethylmonium methosulfate and dipalmitoylethylhydroxyethylmonium methosulfate (B) cholesterol and / or phytosterol (C) containing water. A vesicle composition characterized in that the molar ratio (A) / (B) of component (A) to component (B) is in the range of 100/1 to 1/4 .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011518603A JP5774986B2 (en) | 2009-06-12 | 2010-06-11 | Vesicle composition and cosmetics containing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009141711 | 2009-06-12 | ||
JP2009141711 | 2009-06-12 | ||
PCT/JP2010/060323 WO2010143751A1 (en) | 2009-06-12 | 2010-06-11 | Vesicle composition and cosmetic comprising same |
JP2011518603A JP5774986B2 (en) | 2009-06-12 | 2010-06-11 | Vesicle composition and cosmetics containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2010143751A1 JPWO2010143751A1 (en) | 2012-11-29 |
JP5774986B2 true JP5774986B2 (en) | 2015-09-09 |
Family
ID=43308999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011518603A Active JP5774986B2 (en) | 2009-06-12 | 2010-06-11 | Vesicle composition and cosmetics containing the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5774986B2 (en) |
KR (1) | KR101687432B1 (en) |
CN (1) | CN102802598A (en) |
TW (1) | TWI503129B (en) |
WO (1) | WO2010143751A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101840037B1 (en) * | 2010-10-29 | 2018-03-19 | 가부시키가이샤 코세 | Vesicle composition, and external skin preparation and cosmetic, each contaning same |
KR102066476B1 (en) * | 2013-03-15 | 2020-01-15 | 허큘레스 엘엘씨 | Composition and method of producing personal care compositions with improved deposition properties |
JP6651223B2 (en) * | 2015-03-27 | 2020-02-19 | 株式会社コーセー | Vesicle composition and hair cosmetic containing the same |
JP6419661B2 (en) * | 2015-08-22 | 2018-11-07 | クローダジャパン株式会社 | Skin external preparation composition and skin external preparation containing the skin external preparation composition |
KR20210018595A (en) | 2019-08-06 | 2021-02-18 | 주식회사 잇츠한불 | Vesicle composition having excellent skin permeability and moisturizing power and cosmetic composition containing the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09508167A (en) * | 1994-01-28 | 1997-08-19 | ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチェン | Aqueous solution of ester quart |
JPH10231230A (en) * | 1997-02-19 | 1998-09-02 | Nippon Fine Chem Co Ltd | Cosmetic |
JP2001019634A (en) * | 1999-05-27 | 2001-01-23 | Johnson & Johnson Consumer Co Inc | Novel topical formulation |
JP2007015986A (en) * | 2005-07-08 | 2007-01-25 | Nippon Fine Chem Co Ltd | Lipid dispersion composition, lipid water dispersion composition, and hair cosmetic composition comprising them |
WO2008132816A1 (en) * | 2007-04-17 | 2008-11-06 | Kao Corporation | Hair cosmetic |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1527696A (en) * | 2001-07-13 | 2004-09-08 | 宝洁公司 | Mousse-forming composition comprising a quaternary ammonium agent |
JP2004536839A (en) * | 2001-07-13 | 2004-12-09 | ザ プロクター アンド ギャンブル カンパニー | Mousse-forming compositions containing quaternary ammonium agents |
JP2006182743A (en) * | 2004-12-28 | 2006-07-13 | Kose Corp | Hair conditioning composition |
-
2010
- 2010-06-11 WO PCT/JP2010/060323 patent/WO2010143751A1/en active Application Filing
- 2010-06-11 JP JP2011518603A patent/JP5774986B2/en active Active
- 2010-06-11 TW TW099119345A patent/TWI503129B/en active
- 2010-06-11 CN CN2010800256342A patent/CN102802598A/en active Pending
- 2010-06-11 KR KR1020127000572A patent/KR101687432B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09508167A (en) * | 1994-01-28 | 1997-08-19 | ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチェン | Aqueous solution of ester quart |
JPH10231230A (en) * | 1997-02-19 | 1998-09-02 | Nippon Fine Chem Co Ltd | Cosmetic |
JP2001019634A (en) * | 1999-05-27 | 2001-01-23 | Johnson & Johnson Consumer Co Inc | Novel topical formulation |
JP2007015986A (en) * | 2005-07-08 | 2007-01-25 | Nippon Fine Chem Co Ltd | Lipid dispersion composition, lipid water dispersion composition, and hair cosmetic composition comprising them |
WO2008132816A1 (en) * | 2007-04-17 | 2008-11-06 | Kao Corporation | Hair cosmetic |
Non-Patent Citations (2)
Title |
---|
CSNC200801381025; フレグランスジャーナル、Vol.32, No.6、2004年6月15日、139〜140頁 * |
JPN6014046163; フレグランスジャーナル、Vol.32, No.6、2004年6月15日、139〜140頁 * |
Also Published As
Publication number | Publication date |
---|---|
TW201113045A (en) | 2011-04-16 |
WO2010143751A1 (en) | 2010-12-16 |
KR20120039619A (en) | 2012-04-25 |
TWI503129B (en) | 2015-10-11 |
KR101687432B1 (en) | 2016-12-16 |
CN102802598A (en) | 2012-11-28 |
JPWO2010143751A1 (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5352116B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
TWI632918B (en) | Oil-in-water emulsion skin cosmetic composition and manufacturing method | |
TW201028175A (en) | Oil-in-water type cosmetic | |
TW201733564A (en) | Ripple phase-containing composition, composition for [alpha] gel formation, composition for external application to skin using the same, and [alpha] gel composition | |
JP5774986B2 (en) | Vesicle composition and cosmetics containing the same | |
JP2011256154A (en) | Cosmetic material | |
TW201408329A (en) | Water-in-oil type emulsifying cosmetic | |
TW200400834A (en) | External preparations for skin | |
JP5112673B2 (en) | Ceramide-containing composition and external preparation for skin containing the same | |
JP2006036763A (en) | Water-in-oil emulsion composition | |
JP5483401B2 (en) | Surface treatment powder | |
JP2009234953A (en) | Powdered makeup cosmetic | |
TWI740882B (en) | α-GEL FORMING COMPOSITION AND α-GEL COMPOSITION | |
WO1998054271A1 (en) | Gelling agent and gel compositions | |
JP3682614B2 (en) | Aqueous cosmetics | |
JP2008266274A (en) | Oil-in-water type cosmetic | |
WO2019088056A1 (en) | Oil-in-water type emulsion solid cosmetic | |
TW200303761A (en) | Liquid cosmetics | |
JP2022102419A (en) | Underwater oil drop type emulsion | |
JP3766017B2 (en) | Powder-containing emulsion | |
JP2008303164A (en) | Water-in-oil type solid makeup cosmetic | |
JP2013129625A (en) | Skin care preparation of water-in-oil type emulsion dosage form | |
JP2004051586A (en) | External preparation for skin | |
JP2013129624A (en) | Skin care preparation of oil-in-water type emulsion dosage form | |
WO2024075548A1 (en) | Gel composition and oil-in-water-type composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130408 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140822 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141104 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150609 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150702 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5774986 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |